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1 INTRODUCTION 
 
Campylobacteriosis is the most common food-borne disease worldwide, with a 
reported incidence of up to 177 cases per 100 000 individuals in Europe (EFSA and ECDC 
2013). Nonetheless, the true incidence is estimated to be significantly higher as the disease 
is frequently underreported. In spite of efforts to limit the risk of infection, an increase in 
the number of cases has been registered in the past few years. Poultry is considered as the 
major source of infections, however, raw milk, untreated water, and meat products have 
also been associated with campylobacteriosis (EFSA Panel BIOHAZ 2010). Yet, in most 
cases the source of infection is unknown, as the disease is mainly sporadic. 
Campylobacteriosis is a self-limiting disease characterized by diarrhoea, which 
ranges from mild to bloody. Although most cases resolve within ten days, post-infectious 
complications, such as Guillain-Barré syndrome (GBS), may develop. Variation in the 
disease outcome is most likely influenced by the expression of certain virulence factors 
which are strain specific (Young and others 2007; Poly and Guerry 2008).  
Several typing methods have been developed to characterize campylobacters 
(Penner 1980; Bolton and others 1984; Lior 1984; Grajewski and others 1985; Dingle and 
others 2001). However, most studies have focused on C. jejuni, as  well  as  C. coli to a 
certain extent, as these species are the most commonly reported etiologic agents of 
campylobacteriosis. Pulsed-field gel electrophoresis (PFGE) and multilocus sequence 
typing (MLST) are currently the most commonly used typing methods for C. jejuni and C. 
coli. However, typing of C. coli by both methods may prove challenging as several factors 
may impact the PFGE profile (Hänninen and others 1999; Boer and others 2002; Barton 
and others 2007; Hanel and others 2009; Leblanc-Maridor and others 2011), and the 
limited diversity of clonal complexes among agricultural associated C. coli (Sheppard 2010; 
Sheppard and others 2013). Furthermore, these methods provide limited to no information 
on the pathogenicity or host association, which would be highly desirable for tracking 
routes of contamination and assessing the impact of certain strains to human health. 
This study aimed to assess the distribution of certain genetic markers that have 
been suggested to provide competitive advantages to bacteria or to result in a more severe 
disease outcome. Also, the variation of lipooligosaccharides (LOS) and potential classes, 
and the frequency and characteristics of clustered regularly interspaced short palindromic 
2 
 
 
 
repeats (CRISPRs) in C. coli isolated different sources with the purpose of identifying 
genetic markers which could potentially indicate the source of infection and/or serve in 
outbreak investigations.  
In the first part of the thesis, epidemiology and clinical aspects of Campylobacter, 
particularly C. jejuni and C. coli, are reviewed. In the second part of the thesis, the 
methods for subtyping C. coli isolates are explained. In the final sections, the frequency 
and variation of certain genetic markers, and their relevance to typing methods are 
discussed. 
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2 LITERATURE REVIEW 
 
2.1 Historical background 
Campylobacters were first observed in stool and large intestine mucous of diseased 
neonates by Theodor Escherich in 1886 (Kist 1986). Later, in 1913, McFadyean and 
Stockman isolated for the first time a spiral-shaped, Vibrio-like bacterium from aborted 
ovine foetuses, now known as C. fetus (McFadyean and Stockman 1913; Skirrow 2006). 
These Vibrio-like bacteria became of interest due to its economic impact in animal 
production (Smith and others 1920; Borkenhagen and Letz 1974).  
In 1963 Vibrio fetus and V. bubulus were distinguished from the Vibrio genus due 
to their low G+C content: 29-36% compared to 40-53% in Vibrio spp. Consequently, these 
species were reclassified as C. fetus and C. bubulus (Véron and Chatelain 1973; Charlier 
and others 1974); establishing the Campylobacter genus. Years later, the significance to 
human health of this novel genus was elucidated (Skirrow 1977). 
 
2.2 The genus Campylobacter   
Campylobacter genus belongs to the family Campylobacteraceae along with 
Arcobacter and Sulfurospirillum. Since its establishment, the Campylobacter genus has 
expanded considerably, and currently comprises 25 species and 8 subspecies (Rossi and 
others 2009; Debruyne and others 2010; Debruyne and others 2010; Kaur and others 2011). 
In general, campylobacters are Gram-negative, nonfermenters, nonsporeformers, small 
spiral, curved, or S-shaped rods (0.2–0.8 ?m wide and 0.5–5.0 ?m long), which may 
exhibit a degenerated cocci form in old cultures or under stressful conditions. Also, most 
campylobacters are characterized by a corkscrew-like motion produced by a unipolar or 
bipolar unsheathed flagellum (Vandamme and others 2005; Ebruyned and others 2008). 
Campylobacters are microaerophilic, thus, unable to grow at atmospheric oxygen 
concentrations. Additionally, C. concisus, C. curvus, C. gracilis, C. mucosalis, C. rectus, 
and C. showae require an atmosphere supplemented with 6% hydrogen to grow, while 
some strains of C. jejuni ssp. doyley, C. lari, C. hyointestinalis, and C. upsaliensis exhibit 
enhanced growth under these conditions (Lastovica and Allos 2008). Moreover, the vast 
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majority of campylobacters demand 35 ºC to 37 ºC for optimal growth. Nevertheless,  the 
thermotolerant species of C. avium, C. canadensis, C. coli, C. cuniculorum, C. helveticus, 
C. insulaenigreae, C. jejuni, C. lari, C. peloridis, C. subantarticus, C. troglodytis, C. 
upsaliensis, and C. volucris, may grow at higher temperatures such as 42 ºC (Kaur and 
others 2011). The thermotolerant campylobacters, which are subclustered together by their 
16S rRNA, are of particular importance to human health. Nevertheless, other 
Campylobacter species have also been implicated in human infections (Table 1). 
Table 1. Campylobacter spp. reservoirs and pathogenicity. Adapted from: Stephens and others 1998; 
Humphrey and others 2007; Jerris and others 2010; Man 2011.  
 
Campylobacter 
spp. 
1st description 
Reference 
Source (site of 
detection or 
isolation) 
Possible 
pathogenicity in 
humans  
Pathogenicity in 
animals 
C. avium (Rossi and others 
2009) 
Poultry * * 
C. canadensis (Inglis and others 
2007) 
Whopping crane * * 
C. coli (Doyle 1948) Birds, cattle, 
poultry, goat, 
human, swine, 
sheep, dogs, 
monkey,  
Gastroenteritis, 
septicaemia, 
abortions 
Porcine 
proliferative 
enteritis, 
gastroenteritis, 
hepatitis in 
ostriches 
C. concisus (Tanner and others 
1981) 
Human, poultry, 
beef, cats, dogs 
Periodontal 
disease, 
gastroenteritis 
* 
C. cuniculorum (Zanoni and others 
2009) 
Rabbits  * * 
C. curvus (Tanner and others 
1984) 
Human, dogs Periodontal 
disease, 
gastroenteritis 
* 
C. fetus ssp. fetus (Smith and Taylor 
1919) 
Cattle, sheep, 
horse, kangaroo, 
pet turtle 
Gastroenteritis, 
septicaemia, 
abortion, 
meningitis 
Bovine and ovine 
spontaneous 
abortion 
C. fetus ssp. 
venerealis 
(Florent 1959) Cattle Septicaemia, 
bacteraemia 
Bovine infections 
infertility 
C. gracilis (Tanner and others 
1981) 
Human, dog Periodontal 
disease, empyema, 
abscesses 
* 
C. helveticus (Stanley and others 
1992) 
Cats, dogs * Feline and canine 
gastroenteritis 
C. hominis (Lawson and 
others 2001) 
Human Gastroenteritis Commensal species 
of the intestine 
C. hyointestinalis 
ssp. hyointestinalis 
(Gebhart and 
others 1985) 
Swine, cattle, 
hamsters, 
reindeers, dog, 
sheep 
Gastroenteritis Porcine and bovine 
gastroenteritis 
C. hyointestinalis 
ssp. lawsonii 
(On and others 
1995) 
Swine * * 
C. insulaenigrae (Foster and others 
2004) 
Human, elephant-
seal, porpoise 
carcass, wild seal, 
sea lion 
Gastroenteritis, 
septicaemia  
* 
C. jejuni ssp. jejuni (Jones and others Poultry, swine, Gastroenteritis, Gastroenteritis, 
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1931) cattle, sheep, dogs, 
cats, water, birds, 
mink, rabbits, 
insects, bulls 
septicaemia, 
meningitis, 
bacteraemia, 
abortion, proctitis, 
GBS 
avian hepatitis 
C. jejuni ssp. doley (Steele and Owen 
Int J Sys)   
Human Gastroenteritis, 
gastritis, 
septicaemia 
* 
C. lanienae (Logan and others 
2000) 
Cattle, human, 
swine, sheep 
* * 
C. lari ssp. 
concheus 
(Debruyne and 
others 2009) 
Human, molluscs * * 
C. lari ssp. lari (Debruyne and 
others 2009) 
Birds, cattle, cats, 
dogs, horses, 
poultry, donkey, 
water, molluscs,  
Gastroenteritis, 
septicaemia 
Avian 
gastroenteritis 
C. mucosalis (Lawson and 
Rowland 1974) 
Swine, dogs * Porcine necrotic 
enteritis and ileitis 
C. peloridis (Debruyne and 
others 2009) 
Human, shellfish * * 
C. rectus (Tanner and others 
1981) 
Human, dog Periodontal disease * 
C. showae (Etoh and others 
1993) 
Human, dog Periodontal disease * 
C. sputorum ssp. 
bubulus 
(Florent 1953) Human, cattle, 
swine, sheep 
* * 
C. sputorum ssp. 
sputorum 
(Tunnicliff 1914) Cattle, sheep Abscesses, 
gastroenteritis 
* 
C. subantarticus (Debruyne and 
others 2010) 
Black-browed 
albatross, gentoo 
penguin, grey-
headed albatross 
* * 
C. troglodytis (Kaur and others 
2011) 
Chimpanzee * * 
C. upsaliensis (Sandstedt and 
Ursing 1991) 
Human, dogs, cats Gastroenteritis, 
septicaemia, 
bacteraemia, 
abscesses, 
abortions 
Canine and feline 
gastroenteritis 
C. ureolyticus (Jackson and 
Goodman 1978) 
Human, horses Necrotic or 
gangrenous lesions 
* 
C. volucris (Debruyne and 
others 2010) 
Black-headed gull * * 
*None at the present 
 
2.3 Epidemiology  
 
2.3.1 General aspects 
Campylobacteriosis remains one of the leading causes of bacterial food-borne 
illness worldwide, specifically C. jejuni and C. coli being the most frequently reported 
etiologic agents. The World Health Organization (WHO) estimates that 5 to 14% of all 
gastrointestinal disorders in the world are caused by campylobacters (WHO 2012). Solely 
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in the European Union (EU) the number of confirmed cases of campylobacteriosis in 2011 
was 220 209; with an average notification rate of 50.28 per 100 000 population (EFSA and 
ECDC 2013). Nevertheless, the notification rate of confirmed cases of campylobacteriosis 
varies significantly between EU Member State (MS). The lowest rate in 2011 was reported 
by Latvia, 0.31 cases per 100 000 population, while the highest by the Czech Republic; 
177.95   (EFSA and ECDC 2013). In Finland, the number of confirmed cases per 100 000 
inhabitants has been continuously above the European average, but remains stable (Figure 
1). In contrast, the EU notification rate of confirmed cases has been continuously 
increasing despite efforts to limit the risk of infection (EFSA 2009; EFSA 2010; EFSA 
2011; EFSA 2011; EFSA and ECDC 2012; EFSA and ECDC 2013).  
 
Figure 1. Confirmed cases of human campylobacteriosis per 100 000 population in the EU and Finland 
2007-2011. Adapted from EFSA 2009; EFSA 2010; EFSA 2011; EFSA and ECDC 2012; EFSA and ECDC 
2013 . 
Although the Zoonoses Directive 2003/99/EC requires MSs to monitor and collect 
data on Campylobacter infections, it has been estimated that as many as nine million cases 
of campylobacteriosis occur each year, since the disease is frequently unreported (EFSA 
2010; EFSA 2011). Consequently, the direct and non-direct healthcare costs, and 
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production lost to society due to campylobacteriosis may amount to 2.4 billion euros 
(EFSA 2011). Thus, campylobacteriosis represents a significant burden to the health sector 
and to society. 
 
2.3.2 Sources of infection 
 
Campylobacters are widely distributed in nature, since they have been found to be 
part of the microbiota of a large variety of wild and domesticated animals (Table 1). 
However, farmed animals appear to be the main source of Campylobacter infections in 
humans (Wilson and others 2008). Ruminants and poultry in particular have been 
identified as an important risk factor in various case studies (Man 2011) (Table 2).  
 
 
Table 2. Risk factors for campylobacteriosis identified in case-control studies 
 
Country Identified risk factors Reference 
Australia Travelling, consumption of chicken products including purchased 
barbeque chicken, and offal, contact with puppies and chickens 
 
(Stafford and others 
2007) 
Denmark Travel abroad, consumption of undercooked chicken, and meat 
barbecued over open fire, eating grapes (?), drinking raw milk, 
especially during cold-months, and contact with kittens. 
 
(Neimann and others 
2003) 
Finland Tasting or eating undercooked chicken meat, drinking untreated 
dug well water, and swimming in natural sources of water 
 
(Schönberg-Norio and 
others 2004) 
Netherlands Consumption of chicken and beef products (especially if prepared 
in the grill, microwave, or barbeque), raw milk, and internal organs 
of  animals  (C. coli). Also, ownerships of puppies and cats, use of 
proton pump inhibitors, contact with farm animals, travelling, and 
swimming in open water (C. coli). 
 
(Doorduyn 2010) 
Norway Preparing raw chicken and eating it, consuming undercooked pork, 
drinking non-disinfected water and raw milk, contact with farm 
animals, children playing in areas with bird droppings, cat 
ownership, and barbecuing. 
 
(Kapperud and others 
2003) 
Spain Consumption of chicken and deli meats (unhygienically handled), 
and contact with animals 
 
(Fajó-Pascual and 
others 2010) 
UK Chicken consumption (especially if commercially prepared) , use 
of acid-suppressing medications, infrequent raw milk users, new 
dog owners 
 
(Tam and others 2009) 
US Contact with farm animals. Poultry husbandry increased the risk of 
campylobacteriosis seven times more when compared to the 
husbandry of other species. 
(Potter and others 
2003) 
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A recent risk assessment estimates that 20% to 30% of campylobacteriosis cases 
are linked to handling, preparation, and consumption of chicken meat, whereas 50% to 80% 
of the cases are related to poultry in some way (EFSA Panel BIOHAZ 2010).  
 
2.3.3 Prevalence of Campylobacter in the food-chain 
 As previously mentioned, poultry is considered as the most likely source of 
campylobacteriosis in humans. In a recent baseline survey in the EU, the incidence of 
Campylobacter in broiler carcasses according to detection and enumeration methods was 
on average 51.0% (EFSA 2010). However, prevalence in the MSs varied from 4.9% to 
72.0%. Remarkably, a correlation between the incidence of Campylobacter in broiler 
carcasses and the number of confirmed cases of campylobacteriosis was not observed in all 
MSs (EFSA 2010; EFSA 2010). High prevalence of Campylobacter in broiler carcasses 
was reported by France (72.0%), Poland (53.5%), and Spain (47.0%). Nonetheless, the 
notification rate of campylobacteriosis in these countries (France; 5.4, Poland; 0.7, Spain; 
11.4)  was  considerably  low  in  comparison  to  the  EU  average.  In  contrast,  Finland  has  a  
low prevalence of campylobacters in broiler carcasses (5.5%), even though several cases of 
domestically acquired campylobacteriosis are reported every year (Hulkko and others 2009; 
Hulkko and others 2010; Jaakola and others 2012).  
In addition to poultry, campylobacters have been occasionally detected in fresh 
pork and bovine meat, ready-to-eat (RTE) minced meat, and other meat products. 
Additionally, other food products such as cheeses, milk, fruit and vegetables, spices and 
herbs, and fishery products, have sporadically tested positive for Campylobacter (EFSA 
and ECDC 2013). 
 
2.3.4 Isolation and identification of Campylobacter  
Countries with high prevalence of campylobacters in the food-chain may have low 
notification rates of campylobacteriosis and vice versa. Additionally, a study in travel-
associated campylobacteriosis in Swedish tourists found no association between the risk of 
acquiring campylobacteriosis while visiting a country and the number of cases of 
campylobacteriosis reported by the country (Ekdahl and Andersson 2004). These observed 
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discrepancies might be due to several factors, including acquired immunity (Tribble 2010), 
and/or the lack of a comprehensive surveillance and reporting system (EFSA 2011; EFSA 
and ECDC 2012), as well as differences in diagnostic sensitivities (EFSA 2011) and 
inappropriate isolation of bacteria in food and clinical samples (Hurd and others 2012). 
Detection of Campylobacter in food products is challenging due to low levels of 
contamination (Oyarzabal and others 2007) and the presence of Campylobacter in viable 
but not culturable (VBNC) state (Chaisowwong and others 2012). A gold standard for the 
isolation and detection of Campylobacter in different food products is not available. 
Nevertheless, most laboratories in the EU follow the ISO 10272:2006 (ISO 2006; ISO 
2006) and NMKL 119 standards (EFSA 2010; EFSA and ECDC 2013), which are 
considered to be equivalent, despite their slight differences (NMKL 2007). 
The ISO 10272-1:2006 standard utilizes an enrichment step in Bolton broth for four 
to six hours at 37 ºC, followed by plating in modified charcoal cefoperazone deoxycholate 
(mCCD) agar and a second medium of own choice, such as Campyfood agar, and 
incubation at 41.5 ºC for 40-48 h under microaerobic conditions (ISO 2006). On the other 
hand, the methods employed in the isolation of campylobacters from clinical samples are 
slightly different from those used in foodstuff. Campylobacters can be detected directly 
from stool samples by carbol-fuchsin Gram-staining (Wang and Murdoch 2004) or by 
culture based methods. Despite its high sensitivity and speed, carbol-fuchsin Gram-staining 
is rarely used in clinical laboratories due to its difficulty level and background present in 
fecal matter. Conversely, culture based methods are by far the most widely utilized (Hurd 
and others 2012). These methods can either include a mixture of antibiotics in the media 
(appendix 1) or employ the filtration technique, which prevents non-motile and/or large 
bacteria to pass and to consequently grow on the culture media (Butzler and others 1973).  
Regardless of the origin of the sample, the method of choice may significantly 
impact the detection and recovery of Campylobacter. Selective media composition 
(Valdivieso-Garcia and others 2007; Jokinen and others 2012), isolation techniques, and 
incubation temperature have been shown to impact the recovery of campylobacters 
(McClurg and others 2002; Maher and others 2003). Consequently, most currently used 
protocols have been shown to underestimate the prevalence of Campylobacter (Oyarzabal 
and others 2013), resulting in a cumulative nine-year false-negative rates of 13.6% and 24% 
for C. jejuni and C. coli, respectively, which is significantly higher when compared to 
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Escherichia coli O157:H7 (7.8%), Salmonella enterica (5.9%) or Listeria monocytogenes 
(7.2%) (Edson and others 2009). 
After isolation of single colonies, confirmation of the genus and identification to 
species’ level may be accomplished by various methods. Even so, the asaccharolytic nature 
of Campylobacter genus and its fastidious growth characteristics limits the number of 
biochemical assays that can be employed to discriminate between species (Vandamme and 
others 2005). The hippurate hydrolysis test, which relies on the detection of glycine, is the 
only biochemical assay that can distinguish between the most frequently reported etiologic 
agents, C. jejuni and C. coli. Therefore, this test is commonly used in clinical laboratories, 
although different sensitivities and result variability levels have been observed between the 
various protocols (Morris and others 1985; Cacho and others 1989; Nakari and others 
2008). Furthermore, the inoculum size and the growth medium used may influence the 
results of the hippurate hydrolysis test (Rautelin and others 1999). For example, a small 
inoculum size and/or retrieving C. jejuni from blood-free medium may increase the 
number of false-negatives (Rautelin and others 1999; Nakari and others 2008). As a result, 
the hippurate test has been discontinued in some laboratories in Finland (Jaakola and 
others 2012). 
In addition to the hippurate hydrolysis test, other biochemical tests such as indoxyl 
acetate hydrolysis and selenite reduction tests, can be used to further discriminate 
hippurate negative Campylobacter isolates. Nonetheless, these tests are rarely used in 
clinical laboratories (Hurd and others 2012), since correct speciation may be compromised 
by strain variability, and molecular methods have replaced in some cases the use of 
biochemical assays for species identification (Persson and Olsen 2005; Al Amri and others 
2007). 
Whole DNA probe detection methods for identification of Campylobacter species 
were developed to overcome the shortcomings of phenotypic tests (Penner 1988; Chevrier 
and others 1989). Soon after, these techniques were replaced by polymerase chain reaction 
(PCR) based techniques, which targeted specific DNA sequences. For example, Linton and 
colleagues (1996) developed a method for identifying the Campylobacter genus and five of 
its  species  based  on  the  amplification  of  genus-conserved  regions  in  the  16S rRNA gene  
sequence and some other species specific regions. Presently, several multiplex-PCR 
targeting genes such as hipO, gyrB, glyA, ceuE,  and  others,  can  differentiate  various  
Campylobacter species simultaneously. Yet, a method capable of identifying all 
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Campylobacter species in a single reaction has not been developed (Denis and others 1999; 
Wang and others 2002; Yamazaki-Matsune and others 2007; Kawasaki 2008).  
Despite the improvements in identification methods, 40% to 46% of human isolates 
are not identified to species level (EFSA 2009; EFSA 2010; EFSA 2011; EFSA and ECDC 
2012; Jaakola and others 2012). Consequently, the prevalence and significance of different 
species may be underestimated. Furthermore, the etiology and population structure of the 
different species may be obscured.  
 
2.4 Clinical aspects of Campylobacter infections 
 
2.4.1 Enteritis 
Campylobacteriosis is an acute diarrheal disease in which severe inflammation may 
affect the intestine, colon, and rectum (Skirrow 1977). Generally, a dose of 500-800 
bacterial cells is enough to cause illness (Black and others 1988), which is in most cases 
characterized by abrupt abdominal pain, profuse watery and/or bloody diarrhoea, fever, 
headache, and dizziness (Skirrow 1977). Additionally, muscular pain, rigors, convulsions, 
and meningismus may be occasionally observed (Pacanowski 2008).   
On average, campylobacteriosis symptoms manifest after an incubation period of 
three days (Smith 2002). Although, an earlier onset and severity of the illness depends on 
the ingested dose (Medema and others 1996; Tribble 2010), virulence of the infecting 
strain (Coid and others 1987; Bacon and others 2000), recently acquired immunity (Tribble 
2010), and health status of the infected person (Monselise 2004; Pacanowski 2008; 
Doorduyn 2010). As a result, Campylobacter infections range from asymptomatic to 
sufficiently acute as to require medical treatment. Although the majority of the patients are 
given supportive treatment to maintain hydration and electrolyte balance, since 
campylobacteriosis is generally self-limiting (seven to ten days), campylobacters can be 
recovered from faeces for several weeks after the initial infection (Ketley 1997; Smith 
2002). 
Antibiotics may be prescribed if prolonged (more than a week) or worsening 
symptoms, or complications are observed, or if the patient is pregnant or 
immunocompromised (Smith 2002; Monselise 2004; Rapp 2007; Pacanowski 2008). 
12 
 
 
 
Ciprofloxacin and erythromycin are usually the antibiotics of choice to treat 
campylobacteriosis for various reasons: low rate of resistance among strains, safe for 
children and pregnant women, less likely to affect intestinal microflora, easy to administer, 
and low cost (Acheson and Allos 2001; Taylor and Tracz 2005). Nevertheless, other 
macrolides such as clarithromycin and azithromycin, and tetracyclines, have also been 
used to treat the infection (Engberg and others 2001; Rapp 2007). However, several strains 
have exhibited antibiotic resistance (de Jong and others 2012), causing complications 
especially in patients with an underlying condition (Engberg and others 2001; Monselise 
2004; Rapp 2007; Pacanowski 2008; Fitzgeralde and others 2008).  
 
2.4.2 Bacteraemia 
Though seldom, campylobacteriosis may lead to bacteraemia. The reported 
incidence of bacteraemia ranges from 0.1-1% of the campylobacteriosis cases (Samuel and 
others 2004; Fernández-Cruz and others 2010; Feodoroff and others 2011), being elderly, 
immunocompromised, or patients with underlying conditions overly represented 
(Pacanowski 2008; Nielsen and others 2010; Man 2011; Nadorlik and others 2012). 
Nonetheless, the actual incidence might be significantly higher since the majority of 
bacteraemia symptoms overlap with Campylobacter enteritis  and  blood  samples  are  
generally taken from febrile patients only. Furthermore, the rate of detection of 
campylobacters in blood cultures may be dependent on the type of blood culture system 
employed (Rapp 2007; Nielsen and others 2010).  
Bacteraemia may lead to other complications such as peritonitis, angiocholitis, 
endocarditis, septic arthritis, cellulitis, meningitis, pneumonia, thrombophlebitis, renal 
failure, and shock (Monselise 2004; Rapp 2007; Pacanowski 2008; Fernández-Cruz and 
others 2010). As a result of these complications and the health status of bacteraemia 
patients, a mortality rate ranging from 4-15% has been observed (Pacanowski 2008; 
Nielsen and others 2010). 
 
2.4.3 Sequels 
In  some  rare  cases  complications  such  as  reactive  arthritis  (ReA),  Guillain-Barré  
syndrome (GBS), irritable bowel, Miller Fisher syndrome (MFS), and others, may develop 
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after campylobacteriosis (Table 3). However, campylobacteriosis seldom leads to death. A 
study by CDC estimated that approximately 0.005% of Campylobacter infections are fatal 
(Mead and others 1999). Nevertheless, the fatality rate in the EU was 0.02% and 0.22% for 
2007 and 2008, respectively (EFSA 2009; EFSA 2010), while significantly higher rates 
may be observed in immunocompromised patients (Rapp 2007; Pacanowski 2008). 
Table 3. Characteristics of post-campylobacteriosis-diseases. Adapted from: Smith 2002; Kozminski 2008.  
Disease Incidence in 
Campylobacter 
infected patients 
Characteristics Time of clinical 
recovery 
Mortality 
rate 
GBS 0.1% Autoimmune inflammatory disease of 
peripheral nerves, which cases from 
mild to severe muscle weakness. 
200 days 2% 
IBS 5%-36% constipation, diarrhoea, bloating, 
abdominal pain before and/or after 
bowel movements, frequent bowel 
movements, urgency of defecation 
Highly variable none 
MFS 0.005% Abnormal muscle coordination, 
ophthalmoplegia, areflexia  
2-4 weeks 2% 
ReA Approximately 2% 
but higher 
incidence might be 
observed in 
populations with 
high prevalence of 
HLA-B27 gene  
Sterile inflammation of the joints 
caused by and exogenous infection. The 
affected joints appear tender, warn, 
swollen, and are painful to move 
3-12 months, but 
15-20% of patients 
suffer chronic 
arthritis  
none 
 
2.4.4 Outbreaks 
Poultry, raw milk, water, and other meat products have been implicated in 
Campylobacter outbreaks (Unicomb and others 2009; Pires and others 2010; EFSA and 
ECDC 2012). However, the number of outbreak cases is significantly smaller in 
comparison to sporadic cases, as Campylobacter infections  are  primarily  sporadic  (Olson  
and others 2008). In 2011, campylobacters were the causative agent in 10.6% of the 
reported outbreaks, involving 2 225 human cases (EFSA and ECDC 2013). Thus, only 
1.01% of campylobacteriosis cases were related to an outbreak. Yet, the frequency of 
Campylobacter outbreaks may be underestimated (Takkinen 2003; Much and others 2009; 
Kai 2012) due to the large number of sporadic cases, the absence of routine subtyping, and 
the use of subtyping methods with inappropriate discrimination power (Unicomb and 
others 2009; Pires and others 2010). 
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2.5 Epidemiological methods 
  Multiple phenotypic and genotypic subtyping methods are available to determine 
relationships between isolates (Figure 2). Thus, they can be utilized for epidemiological 
surveillance, outbreak investigations, source tracking, and bacterial population genetics. 
Nevertheless, the discrimination power and level of complexity varies among the different 
methods. As C. jejuni and C. coli are the most frequently reported causative agents of 
campylobacteriosis, the following sections present the subtyping methods used for these 
species. 
 
Figure 2. Commonly used typing methods.  Adapted from: Moore and others 2010. 
 
 
2.5.1 Phenotypic subtyping  
 Phenotypic subtyping methods (Table 4) were developed with the purpose of 
distinguishing between strains when molecular tools were limited.  
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Table 4. Phenotypic subtyping methods commonly used for distinguishing between different Campylobacter 
strains 
Method Reference Principle 
Biotyping (Skirrow and Benjamin 1980; 
Lior 1984; Bolton and others 
1984) 
Campylobacter strains  are  tested  for  grow  at  28  °C,  
hippurate and DNA hydrolysis, H2S production, in 
addition to several resistotyping tests.  
Serotyping (Penner 1980; Lior 1982) Strains are tested for different soluble heat-stable (Penner 
scheme) or heat labile (Lior scheme) antigens by 
agglutination. 
Phage typing (Grajewski and others 1985; 
Salama and others 1990; 
Khakhria and Lior 1992; Frost 
and others 1999) 
Based on the susceptibility of strains to bacteriophages. 
  
Phenotypic methods are advantageous in the sense that large number of isolates can 
be screened. Nevertheless, their discrimination power is significantly lower when 
compared to molecular methods (Wassenaar and Newell 2000). For example, the 
discrimination power of biotyping depends on the number of metabolic and resistotyping 
tests included in a scheme. Due to the limited number of tests, the Lior biotyping scheme 
(1984) classifies C. coli strains into two biotypes only. Conversely, the Preston scheme 
(Bolton and others 1984) may generate a theoretical total of 256 different biotypes. 
However, in practice the number of distinct biotypes may be significantly lower 
(Fitzgerald and others 2001). 
 Phenotypic subtyping methods are considered to have a lower reproducibility than 
genotypic methods due to various factors. Reproducibility of resistotyping tests depends on 
growth  media  and  inoculum  size  (On  and  Holmes  1991)  and  slight  variations  in  the  test  
conditions may have an impact on the results (On and Holmes 1991). Moreover, 
discrepancies  in  the  results  of  serotyping  tests  may be  observed  due  to  differences  in  the  
degree of antigen expression, phase-variability, or after storage of isolates (Salama and 
others 1990; Wassenaar and Newell 2000). 
Other main difficulties encountered by these methods are untypeability and poor 
resolution power, especially for C. coli strains (Gibson and others 1995; Moore and 
Madden 2003). In a study by Frost and others (1999), 183 C. coli strains generated 12 
phage-types (PT), while C. jejuni generated only 57. Two PT accounted for 75.2% of the C. 
coli isolates, while 6 PT were represented by a single colony. Additionally, a PT could not 
be designated to 8.7% of the C. coli isolates. Therefore, phenotypic subtyping methods 
may be more suitable for first line investigations in epidemiological studies (Nielsen and 
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others 2000; Clark and others 2003), but genotypic subtyping might be required for further 
strain differentiation, especially for identifying outbreak-related isolates (Frost and others 
2002; Clark and others 2003). 
 
2.5.2 Genotypic subtyping  
A large number of genotypic methods for subtyping campylobacters are available 
(Figure 4). Nevertheless, pulsed-field gel electrophoresis (PFGE) and multilocus sequence 
typing (MLST) are the most commonly used typing methods for campylobacters. 
 
2.5.2.1 Pulsed-field gel electrophoresis 
PFGE is a genotypic technique in which the whole bacterial genome is digested 
with infrequent cutting restriction enzymes; producing large DNA fragments. By 
separating the fragments through gel electrophoresis, genetic fingerprint patterns are 
obtained. Isolates with highly similar fingerprints are regarded as clonal (Gürtler 2001; 
Foley and others 2009).  
PFGE is considered as the most discriminatory typing method for campylobacters 
after whole genome sequencing (Pendleton and others 2013), and is frequently used 
(Nielsen and others 2000; Hedberg and others 2001; Hook and others 2004) in outbreak 
investigations (Fitzgerald and others 2001; On and others 2008). However, difficulties in 
identifying outbreak-related isolates due to PFGE’s high discrimination power have been 
reported (Hedberg and others 2001; Clark and others 2003). Additionally, concerns on the 
reproducibility  and  stability  of  PFGE  patterns  have  arisen,  as  it  has  been  shown  that  
inconsistencies in electrophoretic conditions (Wassenaar and Newell 2000), passage 
through the intestine (Hänninen and others 1999; Hanel and others 2009; Leblanc-Maridor 
and others 2011), acquisition, loss or transposition of a bacteriophage (Barton and others 
2007), and frequent recombination events (Boer and others 2002) may impact PFGE 
profiles. Despite all, PFGE is considered the gold standard of molecular typing methods 
due to its high discrimination power, typeability, sensitivity, and resolution (Nielsen and 
others 2000; Wassenaar and Newell 2000; Abley and others 2012). 
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2.5.2.2 MLST 
 In MLST, the genetic variation in several housekeeping genes is utilized for lineage 
identification, epidemiological investigations, and strain characterization (On and others 
2008). This technique was first described for Neisseria meningitidis (Maiden and others 
1998). Later on, MLST was adapted to C. jejuni by Dingle and others (2001), based on the 
genome sequence of C. jejuni NCTC 11168. Afterwards, the method was modified to suit 
C. coli and other Campylobacter species (Dingle and others 2001; Lang and others 2010). 
The currently used MLST protocol for C. jejuni and C. coli is  based  on  the  partial  
sequencing of seven housekeeping genes: aspA, , glnA, gltA, glyA, pgm, tkt, and uncA 
(Miller and others 2005). Each unique locus sequence is identified by an allele number, 
which is assigned according to the order of discovery. Then, a sequence type (ST) 
designation is given to every allele profile.  Isolates with identical  or very similar STs are 
considered to share a recent common ancestor, while those with different ST are unrelated 
(Urwin  and  Maiden  2003).  In  the  case  of  campylobacters,  a  seven-digit  allele  profile  is  
assigned a ST according to those already present in the database 
(http://pubmlst.org/campylobacter/). STs may be further categorized into clonal complexes 
(CCs). A CC is comprised by STs that are similar to a central allelic profile, from which 
the name of the CC is derived.  
MLST present numerous advantages over other molecular methods (Pérez-Losada 
and others 2013). First, as a sequence based method, MLST is virtually free of 
experimental variation, hence interlaboratory comparisons are possible. Second, all data 
generated can be shared, compared, and stored in global databases (Maiden and others 
1998; Urwin and Maiden 2003). Third, C. jejuni and C. coli are clearly identified, and 
interspecies horizontal gene transfer can be observed (Schouls and others 2003; Wilson 
2009; Behringer and others 2011). Finally, MLST is insensitive to genome instability 
(Dingle and others 2005). Yet, the relatively high cost of sequencing limits the use of 
MLST for routine surveillance.  Additionally,  MLST relies on highly conserved genes not 
subjected to evolutionary pressure, which decreases the sequence diversity among isolates. 
This is especially true in C. coli, as the vast majority of the isolates obtained today exhibit 
low diversity (Sheppard and others 2012; Sheppard and others 2013). Thus, MLST is more 
suited for population genetics studies than for outbreak identification and short-temporal 
scales (Sails and others 2003; Clark and others 2012). Nonetheless, the discrimination 
power of MLST may be increased by including genes with higher evolutionary rates, such 
as virulence factors, into the subtyping scheme (Liu and others 2011). 
18 
 
 
 
2.5.2.3 Virulence and metabolic genes 
Unlike housekeeping genes, virulence factors are subjected to selection pressure 
leading to high evolutionary rates. In bacteria such as S. enterica and L. monocytogenes, 
the inclusion of virulence factors in typing has shown to increase the discrimination power 
of different methods, particularly MLST (Zhang and others 2004; Liu and others 2011). 
Although, C. jejuni and C. coli are the most common cause of food-borne illness, 
little is known of the virulence mechanisms of these species (Young and others 2007; Poly 
and Guerry 2008). Very few classical virulence factors, including cytolethal distending 
toxin, have been found in the genome (Parkhill and others 2000). As a result, accessory 
genes overrepresented in human isolates and putative virulence factors have been targeted 
in the development of typing methods attempting to elucidate the risk to human health of 
individual strains and to assess the distribution of these genes among C. jejuni isolates 
(Cornelius and others 2010). However, polymorphism in the primer binding regions and 
variation in the pathogenic potential due to single nucleotide polymorphism (SNP) (Duong 
and Konkel 2009) may decrease the effectiveness of this approach. Alternatively, a typing 
method based on the variability of accessory genes distributed among the 16 major 
hypervariable regions of C. jejuni has been recently published (Taboada and others 2012). 
However, up to the time of writing and to the author’s knowledge, no similar attempt has 
been made for C. coli.  
Accessory genes, especially those related to metabolism, may enhance the 
competitiveness of campylobacters which tend to have limited growth capacity due to 
complex nutritional requirements (Muraoka and Zhang 2011). The strain specific genes 
such as fucose permease (fucP) and ?-glutamyltranspeptidase (ggt) permit the utilization of 
a wider range of nutrient sources. As previously mentioned, the Campylobacter genus is 
generally asaccharolytic. Nevertheless, genes involved in L-fucose metabolism have been 
identified in C. jejuni (Muraoka and Zhang 2011; Stahl and others 2011). Strains capable 
of metabolizing L-fucose have been shown to exhibit enhanced growth, increased viability, 
and in some cases increased colonization (Stahl and others 2011). Conversely, ggt is a 
periplasmic enzyme that catalyses the transpeptidation of the ?-glutamyl group of 
glutathione, as well as the hydrolysis of glutamine and glutathione. It has been shown that 
even though the mutant ?ggt of the C. jejuni 81116 strain had higher invasion in vitro and 
increased motility compared to the parental strain, ggt contributes to the persistence of the 
bacteria in the avian gut (Barnes and others 2007). Moreover, other authors have 
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demonstrated that the lack of this enzyme in the C. jejuni 81-176 lead to a significant 
impaired mouse colonization (Hofreuter and others 2006; Barnes and others 2007). 
Therefore, the presence of fucP or ggt may result in more severe or longer infections, 
although  a  weak  correlation  between  the  presence  of  these  genes  and  the  severity  of  the  
disease has been observed (Fearnley and others 2008; Feodoroff and others 2011). 
Although various studies have assessed the distribution of ggt and fucP in C. jejuni 
(Muraoka and Zhang 2011; Zautner and others 2011; Gripp and others 2011; de Haan and 
others 2012), the frequency of these genes in C. coli from different hosts is yet to be 
determined. 
Among the approximately 22 variable regions in C. jejuni, one of the most variable 
regions is the one involved in lipooligosaccharides (LOS) biosynthesis (Young and others 
2007; Poly and Guerry 2008). LOS are outer membrane structures in Gram negative 
bacteria,  which  differ  from  lipopolischarides  by  the  absence  of  the  O  antigen  and  an  
extended core region. LOS interact directly with the host, thus playing a major role in 
virulence,  particularly  in  the  activation  of  TLR4.  At  the  time of  writing,  22  LOS classes  
have been identified in C. jejuni (Parker 2005; Parker and others 2008; Richards and others 
2013), while only nine in C. coli (Richards and others 2013). Among C. jejuni classes five 
are sialylated (A, B, C, M and R classes). Sialylated LOS classes have been shown to 
invade cells more frequently than those that are non-sialylated, and to confer serum 
resistance (Guerry and others 2000). Additionally, sialylated LOS classes have been 
associated with GBS, as they seem to mimic the ganglioside structures causing an 
autoimmune response. Furthermore, C. jejuni sialyltransferase type II (cst-II) appears to 
provide bacteriophage resistance to bacteria in place of the more common bacterial 
immune system: clustered, regularly interspaced short palindromic repeats (CRISPRs). 
CRISPRs, as the name suggests, are composed of identical repeats containing a palindrome 
ranging from 27 to 50 nucleotides interrupted by unique sequences called spacers 
(Barrangou and Horvath 2012). These spacers have been shown to be mainly acquired 
from bacteriophages (Sorek and others 2013). CRISPRs have been identified in various C. 
jejuji strains (Schouls and others 2003; Price and others 2007), while C. coli has been 
predominantly considered as CRISPR negative (Fouts and others 2005). However, the 
number of C. coli strains screened for CRISPRs has been limited to 12 (Schouls and others 
2003; Fouts and others 2005; Price and others 2007). In bacteria such as Salmonella 
CRISPRs have proven to be a useful tool for epidemiological investigations (Shariat and 
others 2013).  
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EXPERIMENTAL RESEARCH 
 
3 AIMS OF THE STUDY 
 Although the vast majority of research to date has focused on C. jejuni, the aim of 
this thesis was to characterize C. coli isolates from different sources by evaluating certain 
genetic markers among C. coli. The specific aims were: 
1. To determine the distribution of ?-glutamyltranspeptidase. 
2. To determine the distribution of several genetic markers, including: fucP, cst-I, cst-
V and cytC. 
3. To study  the  diversity  of  LOS in  C. coli and determine the potential LOS classes 
distribution among Finnish isolates. 
4. To evaluate the possibility of using CRISPR sequences as a subtyping method for 
C. coli. 
 
4 MATERIALS AND METHODS 
 
4.1 Bacterial isolates 
 A total of 194 Campylobacter isolates  were  selected  from  the  collection  of  Prof.  
Marja-Liisa Hänninen. Isolates were retrieved from storage at -70 ºC and routinely cultured 
on Nutrient broth nº2 (CM0067, Oxoid Ltd. Basingstoke, UK) with 1.5% (w/v) of agar 
(Laboratories Conda, Madrid, Spain), and supplemented with 5% (v/v) of defibrinated 
horse blood (NA plates). All strains were incubated at 37 ºC for 24 to 48 h under 
microaerobic conditions (85% N2, 10% CO2, 5% H2) using the gas replacement method. 
 
4.2 Identification of Campylobacter isolates 
 
4.2.1 Hippurate hydrolysis 
All Campylobacter cultures were tested for hippurate hydrolysis, as previously 
described by Skirrow and Benjamin (1980) with some modifications. In brief, bacteria 
were collected from NA plates and inoculated in tubes containing 400 µl of 1% (w/v) 
sodium hippurate solution (Merck, Darmstadt, Germany). The tubes were incubated in a 
water bath at 35 ºC for 2 h, and 200 µl of ninhydrin solution (3.5 g of ninhydrin (Merck) in 
100 ml of a 1:1 (v/v) mixture of acetone and butanol) were added. Finally, the tubes were 
re-incubated for a further ten minutes for colour development. Strains C. jejuni ATCC 
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33560T and C. coli CCUG 33450 were used as positive and negative controls, respectively. 
A positive test was determined as a dark, crystal violet-like colour. Hippurate positive 
isolates were excluded from further testing. 
Isolates giving a colourless or a lilac-coloured result were subculture and frozen in 
skim  milk  with  10%  (v/v)  glycerol  at  -70  ºC.  Additionally,  DNA  was  extracted  from  all  
hippurate-negative isolates with Wizard Genomic DNA purification kit (Promega, 
Madison, WI, USA) or DNeasy tissue and blood kit (Qiagen, Cedex, France) following the 
manufacturers’ instructions. Concentration and quality of the DNA extractions were 
determined using NanoDrop-1000 Spectrophotometer (Thermo Fisher Scientific Inc., 
Waltham, MA, USA), and dilutions of approximately 15 ng/µl were prepared and stored at 
-20 ºC until further use.  
 
4.2.2 Multiplex-PCR for genus and species identification 
The hippurate-negative isolates were further tested with a multiplex-PCR (m-PCR) 
developed by Denis and others (1999) for Campylobacter genus and species identification 
(in particular C. jejuni and C. coli). Genes intrinsic to the genus (16S rRNA), C. jejuni 
(mapA), and C. coli (ceuE) were amplified (Table 5). 
Table 5. Sequence of primers sets and product lengths for the different genes screened in this study 
Gene Primer sequence (5’?3’) Produc
t (bp) 
Reference 
16S rRNA F: ATC TAA TGG CTT AAC CAT TAA AC 857   (Denis and 
others 1999) R: GGA CGG TAA CTA GTT TAG TAT T  
mapA F: CTA TTT TAT TTT TGA GTG CTT GTG  589 
R: GCT TTA TTT GCC ATT TGT TTT ATT A  
ceuE F: AAT TGA AAA TTG CTC CAA CTA TG  462 (Denis and 
others 1999) 
R: TGA TTT TAT TAT TTG TAG CAG CG  (Denis and 
others 1999) 
fucP F: GAT AGA GCA TTA AAT TGG GAT G 1200 (Fearnley and 
others 2008) R: CCT ATA AAG CCA TAC CAA GCC 
Partial 
sialyltransferase 
(encoded in LOS, 
cst-V ) 
F: TTC CTT TGC AAC ACG AAA TAA  449 This study 
R: GTT TTG GAG CTA GCG GAA TA  
cytC F: ATC GAC GAT GTT CCA AAA  645 This study 
R: AGG ATT ATC CGC ACT TCG AC   
Sialyltransferase 
(encoded in the 
CPS, cst-I) 
F: GCA ATT GCA TTG GGA TAT AA  603 This study 
R: CAC AAT TAG CAG CTT GTC CTT   
CRISPRs F:GCA ACC TCC TTT TAG TGG AGT AAT 400-
2000 
(Price and 
others 2007) R: AAG CGG TTT TAG GGG ATT GTA AC 
ORF3 F1: TTG GGG TAG AGA AGA TAG TGA GTT TGT ---- This study 
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AGC 
F2: AAA AGC TTG TGG CTG GTG GCC TGA TCA This study 
waaV R: AAG AGC TTT GCA AAG CTG TAT AAA TCA 
GAC 
This study 
 
The amplification reactions were performed in a 25 µl volume containing 1 U Taq 
polymerase (Finnzymes, Espoo, Finland), 200 µM of each dNTP (Fermentas, Vilnius, 
Lithuania), 0.4 µM of mapA and ceuE primers, 0.2 µM of 16S rRNA primers (Oligomer 
Oy, Helsinki, Finland), 1 X Dynazyme buffer (Finnzymes), and 2 µl template. Cycling 
conditions were as follows: initial denaturation at 94 ºC for ten minutes, followed by 35 
cycles of denaturation at 94 ºC for 30 s,  annealing at 59 ºC for 90 s, extension at 72 ºC for 
one minute, and a final elongation at 72 ºC for 10 minutes.  
To visualize PCR products, 5 µl aliquots + 1 µl ficoll bromophenol were subjected 
to electrophoresis in a 1.5% (w/v) agarose gel (BMA, Rockland, Maine) stained with 100 
µg of ethidium bromide (Amresco, Solon, OH, US) in 1 X TAE buffer (Amresco) for one 
hour at 110 V and viewed under UV light (Alpha Imager, US). Molecular weight marker 
VII (Roche, Basel, Switzerland) was used to estimate the size of the bands, and strains C. 
jejuni ATCC 33560T and C. coli CCUG 33450 were used as controls. 
In total, a collection of 145 C. coli isolates from different sources (2 goose, 18 
poultry, 35 human and 90 swine) was obtained.  
 
4.3 GGT activity 
 C. coli isolates  were  tested  for  GGT  activity  as  described  by  de  Haan  and  others  
(2012) with some modifications. In brief, isolates were retrieved from NA plates, 
inoculated into 500 µl of phosphate buffered saline (PBS), and centrifuged to obtain a cell 
pellet. Then, the pellet was resuspended in 500 µl of reagent containing 100 mM Tris, 2.9 
mM L-glutamic acid ?-3-carboxy-4 nitroanilide) (Sigma-Aldrich, St. Louis, MO, US) and 
100 mM glycylglycine (Sigma). Suspensions were incubated at 37 ºC for 30 minutes. An 
isolate was determined as GGT positive if suspensions appeared bright yellow (Revez and 
others 2011). The strain C. jejuni 81-176 was used as positive control, while C. jejuni 
NCTC 11168, and C. coli CCUG 33450 were used as negative controls.  
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4.4 Screening of fucP 
 C. coli strains were screened for fucP according to Fearnley and others (2008) with 
some  modifications.  Briefly,  amplification  reactions  of  25  µl  were  made  containing  1  U  
Taq  polymerase  (Finnzymes),  200  µM  of  each  dNTP  (Fermentas),  0.4  µM  of  each  fucP 
primer (Table 5) (Oligomer Oy), 1 X Dynazyme buffer (Finnzymes) and 5 µl of template. 
Cycling conditions are shown on Table 6.  
Table 6. Cycling conditions for the amplification of fucP, sialyltransferases and cytC 
  30 cycles  
 Initial 
denaturation 
Denaturation  Primer 
annealing 
Extension  Final 
elongation 
 ºC Time ºC Time ºC Time ºC Time ºC Time 
fucP 94 3 min 94 30 s 52 30 s 72 30 s  
72 
 
 
5 min 
 
cst-V  
95 
 
5 min 
 
95 
 
 
1 min 
 
53 1 min  
72 
 
1 min 
cytC 55 10 s 1 min 
cst-I 55 30 s 30 s 
 
 Amplicons were visualized as described above in section 4.2.2. Molecular weight 
marker VI (Roche) was used to estimate the size of the bands. The strains C. jejuni NCTC 
11168 and C. jejuni 81-176 were used as positive and negative controls, respectively. 
 
4.5 Screening of sialyltransferases and cytochrome C 
 The laboratory where the present study was performed sequenced one human strain 
of C. coli and is currently analysing it. Based on the information retrieved from this strain 
(76339, EMBL accession HG326877), our isolate collection was screened for the presence 
of  the  following  genes:  partial  sialyltransferase  (cst-V) potentially from the LOS locus, 
cytochrome C (cytC) and sialyltransferase (cst-I) potentially from the capsular locus. A 25 
µl master mix for each primer pair was prepared containing the following; 0.5 U Taq 
polymerase (Finnzymes), 160 µM dNTP (Fermentas), 0.4 µM of each primer (Table 5), 
800 µM of MgCl2 (Finnzymes), 1 X Dynazyme buffer (Finnzymes), and 5 µl template. 
Cycling conditions for the different reactions are shown on Table 6.  
Amplicons were visualized as described above in section 4.2.2. Molecular weight 
marker VIII (Roche) was used to estimate the size of the bands. The strain 76339 was used 
as a positive control, while C. coli CCUG 33450 served as the negative control. 
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4.6 LOS 
 
4.6.1 Amplification of LOS region 
The  LOS regions  were  amplified  in  a  long  PCR with  the  primers  targeting  ORF3 
coding for a two-domain glycosyltransferase (primer ORF3F1) and ORF12 coding for 
lipooligosaccharide biosynthesis glycosyltransferase waaV. Additionally, a second forward 
primer was designed to amplify the LOS region of isolates with one-domain 
glycosyltransferase (ORF3) (primer ORF3F2). The design of this primer was based on the 
C. coli genome  sequences  available  in  the  NCBI  as  well  as  the  genome  from  our  strain  
76339.  
 
4.6.1.1 PCR-optimization  
Primers were tested under the following conditions; two 25 µl reactions containing 
0.5 U Phusion Hot Start high-fidelity DNA polymerase (Finnzymes) or Phusion high-
fidelity (Finnzymes), 200 µM of each dNTP (Fermentas), 0.4 µM of each primer pair 
(ORF3 and waaV or ORF3F2 and waaV), 1 X Phusion GC buffer (Finnzymes), 700 µM of 
MgCl2 (Finnzymes), and 5 µl of template, were prepared. Cycling conditions were as 
follows: one cycle at 98 ºC for 30 s followed by 30 cycles of denaturation at 98 ºC for 10 s, 
a gradient for primer annealing from 55 ºC to 65 ºC for 30 s, extension at 72 ºC for 6 min, 
and a final elongation at 72 ºC for 6 minutes.  
PCR products (8 µl aliquots + 1 µl bromophenol) were subjected to electrophoresis 
in a 1% SeaKem Gold agarose (Lonza) in 1 X TAE buffer (Amresco) for 1.5 h at 130 V. 
Molecular weight marker VII (Roche Germany) was used to estimate the size of the bands. 
The strain 76339 served as the negative control for the primer pair ORF3F1 and waaV. 
 
4.6.1.2 PCR and electrophoresis conditions 
The LOS regions of the C. coli collection were amplified as stated in section 4.6.1.1 
with some modifications. Briefly, phusion high-fidelity polymerase (ThermoScientific) 
was used to prepare the master mix, and primer annealing temperature was 62.4 ºC. For 
electrophoresis of the PCR products (5 µl aliquots + 1 µl bromophenol), a 0.5% SeaKem 
LE agarose (Lonza) gel was used. Products were run at  60 V for 16 h.  Molecular weight 
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markers II, VII, XV (Roche Germany) 1 kb-plus, and long-range (Fermentas) were used to 
estimate the size of the bands. 
4.7 CRISPRs 
 
4.7.1 Screening and sequencing of CRISPRs 
Amplification of the CRISPRs region was performed in 50 µl reactions containing 
2 U Taq polymerase (Finnzymes), 200 µM of each dNTP (Fermentas), 0.4 µM of each 
primer  (Table  5),  1  X  Dynazyme  buffer  (Finnzymes),  and  5  µl  of  template.  Cycling  
conditions  were  as  follows:  one  cycle  at  94  ºC  for  5  minutes  followed  by  40  cycles  of  
denaturation at 94 ºC for 30 s, primer annealing at 54.5 ºC for 30 s, extension at 72 ºC for 
one  minute,  and  a  final  elongation  at  72  ºC for  7  minutes.  Amplicons  were  visualized  as  
described above in section 4.2.2. Molecular weight marker VI (Roche) was used to 
estimate the size of the bands. 
A total of 58 PCR-positive CRISPRs of various sizes and sources were sequenced 
using the CRISPR-F primer (Table 5). 
 
4.7.3 CRISPRs sequence analysis 
 CRISPR sequences were detected with CRISPRFinder (Grissa and others 2007). 
Direct repeats (DR) were identified, and a spacer-dictionary was constructed. The 
distribution of spacers among isolates was determined, and source-specific spacers were 
identified. Additionally, spacer sequences were searched among the C. jejuni libraries 
available at the time (Grissa and others 2007).  
 
5 RESULTS  
 
5.1 C. coli collection 
A total of 186 Campylobacter isolates were tested for hippurate hydrolysis, 159 were 
negative (Figure 3A). Good quality DNA was extracted from all hippurate negative 
isolates, except from five (173, 180, 181, 187, and 194), which DNA quality was 
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unacceptable upon repeated extractions. Then, 155 isolates, including a second isolate from 
sample three, which was deemed to be a mixed culture, were tested by species-specific 
PCR (Figure 3B). From these isolates, three were identified as C. jejuni, seven as 
Campylobacter spp., and 145 as C. coli. The final C. coli collection was comprised by 
isolates obtained from the following sources: two geese, 18 poultry (including four from 
turkey), 35 human, and 90 swine. 
 
 
Figure 3. Phenotypic and genotypic identification of Campylobacter isolates. (A) Hippurate hydrolysis test. 
(B)  Genus and species specific PCR. Lanes: 1, C. jejuni ATCC 33560T; 2, C. coli CCUG 33450; 3, negative 
control. The size of the molecular marker VII is indicated in bp.  
 
5.2 Screening of C. coli collection 
The frequency of the fucP, cst-V, cytC, and cst-I genes  among  the  C. coli isolate 
collection was assessed by PCR (Figure 4).  
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Figure 4. PCR-screening of genes of interest. (A) fucP. (B) cst-I. (C) cytC. (D) cst-V. The sizes of the 
molecular markers are indicated in bp.  
 
Additionally, the collection was screened for the expression of the GGT gene. Results are 
summarized in Table 7.  
 
Table 7. Distribution of fucP, cst-V, cytC, and, cst-I genes, and expression of GGT in the C.coli isolate 
collection. 
 No. (%) of isolates with indicated phenotype (GGT) or genotype/total no. of  isolates 
Source GGT fucP cst-V  cytC  cst-I  
Poultry 0/18 (0) 18/18 (100) 0/18 (0) 0/18 (0) 0/18 (0) 
Geese 1/2 (50) 0/2 (0) 0/2 (0) 1/2 (50)  0/2 (0) 
Human 1/35 (2.86) 28/35 (80) 1/35 (2.86) 1/35 (2.86) 1/35 (2.86) 
Swine 0/90 (0) 85/90 (94.44) 0/90 (0) 0/90 (0) 1/90 (1.11) 
Total 2/145 (1.38) 131/145 (90.34) 1/145 (0.69) 2/145 (1.38) 2/145 (1.38) 
 
The frequency of fucP among C. coli isolates was 90.34%. Moreover, fucP was 
detected in all sources except in geese. Conversely, the frequency of GGT expression 
along with the presence of cytC, and cst-I was 1.38%, while the presence of cst-V genotype 
was  was  revealed  in  only  one  human strain.  Only  one  human isolate  was  positive  for  all  
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markers but fucP negative, while a goose isolate was GGT positive and cytC positive, and 
a swine isolate was cst-I positive.  
5.3 LOS 
 PCR conditions were optimized (Figure 5) for the amplification of the LOS locus 
using two primer pairs; R-F1 and R-F2 (Table 5).  
 
 
Figure 5. Optimization of PCR conditions for the amplification of the LOS locus in C. coli. Lanes 2-10 LOS 
product of isolate 58 amplified with primer pair R-F1. Lanes 13-21 LOS product of strain 76339 amplified 
with primer pair R-F1. Lanes 24-32 LOS product of isolate 58 amplified with primer pair R-F2. Lanes 35-44 
LOS product of strain 76339 amplified with primer pair R-F2. Lanes; 1, 22, 23, and 34, molecular marker II. 
Lanes; 11, and 44 molecular marker VIII. Molecular marker sizes are indicated in bp.  
 
 Subsequently, the LOS locus of the entire C. coli collection was amplified (Figure 
6A) with both primer pairs to estimate the size (Figure 6B) of the LOS locus and determine 
the frequency of one-domain glycosyltransferase.  
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Figure 6. (A) Electrophoresis of LOS-PCR products. Lanes 3-8, and 10-19 LOS product of a selection of C. 
coli isolate amplified with primer pair R-F2. Lanes; 1, 9, and 20 molecular marker GeneRuler high range 
DNA marker (Fermentas). Lane 2 GeneRuler 1 kb DNA ladder (Fermentas). (B) Estimated distribution of 
LOS product sizes amplified with primer pair R-F2. The sizes of the molecular markers are indicated in bp. 
Only four out of the 145 isolates (2.76%) were PCR negative for both primer pairs upon 
consecutive testing (Table 8).  Additionally, 12 isolates (8.51%) were negative for primer 
pair R-F1, but positive for R-F2. Hence, these isolates had a one-domain 
glycosyltransferase instead of a more frequent two-domain glycosyltransferase.  
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Table 8. Frequency of LOS-PCR(-) and one-domain glycosyltransferase among C. coli isolated from 
different sources.  
Source LOS-PCR(-) One domain glycosyltransferase 
Geese 0/2 ½ 
Human 3/35 4/32 
Poultry 1/18 3/17 
Swine 0/90 4/90 
Total 4/145 12/141 
 
 
5.4 CRISPRs 
 A total of 14 isolates out of 145 (9.66%) did not yield a PCR product upon 
consecutive testing (Table 9). CRISPR-PCR products ranged in size from approximately 
300 bp to 2.2 kbp (Figure 7).  
 
Figure 7. PCR screening of CRISPRs. Lane 1-24 C.coli isolates, lane 25 molecular marker VI, sizes are 
indicated in bp.  
 
 A subset of 58 (44.27%) isolates with different sized CRISPRs, were sequenced 
(Table 9).  
 
Table 9. Characteristics of CRISPRs found in C. coli isolates 
Source Strains with 
amplifiable 
CRISPRs 
Strains 
with 
sequenced 
CRISPRs 
Strains 
without 
identifiable 
CRISPRs 
Unique 
CRISPR 
types 
Different 
spacers  
Source-unique 
spacers 
Geese 1/2 1/1 0/1 1/1 3/3 3/3 
Human 28/35 3/28 0/3 3/3 22/22 14/22 
Poultry 17/18 10/17 1/10 9/9 72/80 53/72 
Swine 85/90 44/85 5/44 32/39 209/271 191/209 
Total 131/145 58/131 6/58 45/52 306/376 261/306 
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To be considered as CRISPR positive, an isolate should contain two or more DRs 
consisting of 21 or more bp, separated by unique similar sized spacer sequences. In 
accordance to this definition, six of the sequenced isolates (10.34%) were CRISPR 
negative. The other 52 isolates carried CRISPRs containing from one to 14 spacers (Figure 
8). 
 
Figure 8. Distribution of CRISPRs sizes in terms of number of spacers, among sequenced C. coli isolates. 
Based on the size of the CRISPR-PCR-products and the number of spacers found in 
the sequenced isolates, the number of spacers was estimated for the 73 isolates that were 
not sequenced (Figure 9). 
 
Figure 9. Estimated distribution of CRISPRs sizes in terms of number of spacers, among the CRISPR-PCR 
positive C. coli isolates. 
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Assuming that all non-sequenced CRISPR-PCR positive isolates contained 
CRISPRs, it was estimated that a large proportion of the isolates (58.4%) carried 13 or 
more spacers.  
 
 Sequence analysis of the 52 CRISPR positive isolates revealed extensive spacer 
diversity (Table 9). Only two CRISPR types (CT) were found in more than one isolate 
(Figure 10), while 86.54% of the isolates had a unique CT (Table 9). Repeated CTs were 
only observed in swine isolates.  
 
 
Figure 10. Repeated CTs among sequenced C. coli isolates. (A) CT found in swine isolates; 118, 120, 122, 
130, 131. (B) CT found in swine isolates; 150 and 152. 
 
 Furthermore, 81.38% of the spacer sequences were different within strains obtained 
from the same source. Conversely, 14.71% of the different spacers were found in isolates 
from more than one source (Table 10).  
 
Table 10. Distribution of specific spacer sequences among C. coli isolates from different sources.  
 Geese Human Swine Total 
Human 0   0 
Swine 0 3  3 
Poultry 0 5 15 20 
Total 0 8 15  
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Poultry shared a total of 20 spacers with other sources, while swine 18, and humans 
8. The greatest spacer-overlap was observed between swine-poultry, followed by poultry-
human, and swine-human. The goose isolate had the most unique spacers, as it shares no 
spacer homology with other sources. 
Spacers were further compared against those previously described by Price and 
colleagues (2007) in C. jejuni, and only four spacers were identical (spacers 14, 18, 92, and 
196) (Appendix A.2), while five were different by a single nucleotide (spacers 3, 12, 17, 
208, and 241). 
In contrast, DR sequences were highly (99.3%) conserved among isolates. Only 
three single DR were different from the consensus (Table 11). The quality of the sequence 
was  visually  verified  to  ensure  that  the  differences  in  the  sequences  were  due  to  
polymorphism and not sequencing errors. A third DR showed greater variation, as seven 
nucleotides differed from the consensus DR. 
 
Table 11. Diversity of DRs among sequenced C. coli isolates 
Isolate code Source DR  Frequency 
(%) 
Consensus GTTTTAGTCCCTTTTTAAATTTCTTTATGGTAAAAT 414 (99.30) 
75 Poultry GTTTTAGTCCCTTGTTAAATTTCTTTATGGTAAAAT 1 (0.24) 
67 Human GTTTTACTCCCTTTTTAAATTTCTTTATGGTAAAAT 1 (0.24) 
151 Pig CGTTTTAGTCCCTTTTAAATTTCTTTATGGTAAAAT 1 (0.24) 
 
6 DISCUSSION 
Despite their small genome, the metabolic diversity of campylobacters has 
permitted the colonization of various distinct niches (Parkhill and others 2000; Man 2011; 
Sheppard and others 2013). Thus, subpopulations may be identified based on the different 
secondary metabolic capabilities of the species. Although, metabolism is not considered a 
virulence factor determinant per se, it may, however, increase strain fitness to certain 
conditions. Consequently, by exploring the variation in metabolic traits, a better 
understanding of C. jejuni and C. coli epidemiology, colonization requirements, and 
pathogenicity may be attained. This would result in improved measurements for the 
prevention of Campylobacter infections. In the current work, the distribution of metabolic 
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related genes (GGT, fucP, and cytC), which may confer a competitive advantage, and 
increase survival and persistence, and potential host-interaction determinants 
(sialyltransferases) was assessed in a 145 C. coli isolate collection from different sources.  
Campylobacters are generally regarded as asaccharolytic organisms. Nevertheless, 
the use of L-fucose as a nutrient source by some C. jejuni strains has been described (Stahl 
and others 2011; Muraoka and Zhang 2011), and genes involved in L-fucose metabolism 
have been identified in various C. coli (Fouts and others 2005; Sheppard and others 2013).  
In C. jejuni, strains containing fucP in their genome have shown to exhibit 
enhanced growth and remain viable for longer periods of time than fucP negative strains. 
In pig intestine, fucP provides a competitive advantage to C. jejuni. However, no enhanced 
colonization is observed in chick cecum, although fucosylation levels are similar in both 
mucins. Yet, in L-fucose rich environments or at low levels of campylobacters, fucP may 
proof advantageous, but it is not essential for colonization (Stahl and others 2011; Muraoka 
and Zhang 2011). The fucP gene is located within one of the highly variable plasticity 
regions (PR) present in C. jejuni. The 9.5 kb open reading frame (ORF) containing fucP 
and other genes required for L-fucose utilization is situated between rpoC and rpsL, which 
are two highly conserved genes (Muraoka and Zhang 2011). This ORF cluster is entirely 
absent in fucose permease negative strains. Consequently, to estimate the percentage of C. 
coli isolates capable of utilizing L-fucose as a nutrient source, the distribution of fucP was 
assessed by PCR. This method is more reliable than phenotypic tests, which have shown to 
lack sensitivity. Additionally, the presence of fucP has been observed to predict fucose 
utilization, although other genes in the ORF are also necessary for the phenotype (Muraoka 
and Zhang 2011). In this study the frequency of fucP among C. coli isolates was higher 
(90.34%) than those earlier reported for C. jejuni (30.3% - 64.5%) (Fearnley and others 
2008; Muraoka and Zhang 2011; de Haan and others 2012; Zautner and others 2012). So, 
in agreement with previous observations made by Sheppard and others (2013), C. coli 
appear to harbour the fucose ORF.  
 As fucP provides a competitive advantage to C. jejuni in piglet colonization (Stahl 
and others 2011), it may be hypothesized that at higher frequencies, fucP may be 
encountered in swine isolates. Nonetheless, in agreement with previous studies, no 
association between genotype and source was observed in this study (Muraoka and Zhang 
2011; Gripp and others 2011; de Haan and others 2012). In fact, fucP was  found  to  be  
uniformly distributed among isolates from different sources, except in geese. However, 
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only two isolates from this source were tested, therefore the possibility of a higher 
frequency of fucP in geese isolates cannot be ruled out. Furthermore, one of the geese 
isolates was GGT positive, which has been shown in most of the cases to be mutually 
exclusive with fucP (Muraoka and Zhang 2011; de Haan and others 2012; Zautner and 
others 2012). A similar observation was made in a human isolate, which was GGT positive 
but fucP negative.  
The high frequency of fucP reported in this study might have been due to the 
composition of the isolate collection. Previous studies suggest a strong association between 
certain clonal complexes (CC) and the presence of fucP (Gripp and others 2011; de Haan 
and others 2012; Zautner and others 2012). De Haan and colleagues (2012) reported C. 
jejuni CCs ST-21 and ST-48, to be significantly associated to the presence of fucP, while a 
negative association was observed for CCs ST-22, ST-45, ST-61, and ST-677. Similar 
results were obtained with a smaller isolate collection by Gripp and colleagues (2011), 
where C. jejuni ST-21, ST-48, ST-206, ST-257, ST-443, and ST-607 CCs were fucP 
positive, while ST-45, ST-267, and ST-283 CCs were fucP negative. Thus, a homogenous 
collection,  in  terms  of  CCs  composition,  may  obscure  results.  For  example,  Zautner  and  
colleagues (2012) reported that 57.9% of C. jejuni isolates were fucP positive, and 
suggested that fucP positive isolates were livestock-adapted. Thus, these isolates were less 
prevalent in humans and associated with milder cases of campylobacteriosis. However, 
Zautner and colleagues (2012) agriculture isolate collection was primarily comprised by 
the C. jejuni CCs ST-21, ST-48, ST-206, which are generally fucP positive.  
In contrast to C. jejuni, agricultural and clinical C. coli isolates are mainly limited 
to two CCs; ST-828 and ST-1150 CCs (Sheppard 2010; Sheppard and others 2013), being 
ST-828 the most frequently encounter CCs (84%) (Sheppard 2010; Sheppard and others 
2013). The CCs ST-828 and ST-1150 belong to clade 1 (Figure 11), which is characterized 
by its relatively low MLST diversity, yet higher than in monomorphic organisms, and high 
levels of recombination (Sheppard 2010).  
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Figure 11. Ancestry of C. jejuni and C. coli clades. Adapted from Sheppard and colleagues (2013).  
 
Additionally, ST-828 and ST-1150 are highly introgressed CCs, with 9.7% to 11.2% 
and 20.4% to 22.5%, respectively, of imported C. jejuni DNA. It is then suggested that this 
introgression has resulted in the acquisition of genes involved in L-fucose metabolism 
(Sheppard and others 2013). In the present study, agricultural and clinical isolates 
accounted for 98.62% of the C. coli collection hence the C. coli isolate collection may have 
been mainly comprised of isolates belonging to ST-828, and therefore, explains the 
extremely high frequency of fucP positive and low frequency of GGT positive isolates 
(Figure 14). In agreement with this, in the study by Gripp (2011) the C. coli collection (178) 
obtained from different sources, the CC ST-828 was overly represented (82.58%), 
followed by STs that had not been assigned (UA) to a particular CC (16.85%) but that are 
closely related to ST-828. Only one isolated in Gripp (2011) belonged to the CC ST-1150. 
Furthermore, the MLST typing data available for 20 strains in this study C. coli collection 
representing 19 different STs revealed that 16 isolates belonged to the CC ST-828, while 
four were UA (ST-1240, ST-1968, ST-5088, and ST-6354). Yet, ST-1240 and ST-1968, 
shared five and six alleles, respectively, with other STs (ST-4170 and ST-828) belonging 
to  the  CC  ST-828.  Consequently,  these  two  isolates  also  belong  to  CC  ST-828,  as  they  
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shared more than four alleles in the MLST scheme, although they have not been officially 
assigned to a CC. The ST-5088 and ST-6354 had the most unique alleles, as four out of the 
seven alleles could not be found in any other isolated registered in the MLST database (as 
of 10.6.2013). 
Interestingly, three isolates (two human, one swine) belonging to CC ST-828 (ST-
838, ST-1153, and ST-1614) were fucP negative. Previous studies in C. jejuni suggest that 
generally STs within a CC exhibit the same metabolic traits (Gripp and others 2011; de 
Haan and others 2012). However, some C. jejuni CCs such as ST-22 and ST-45 in may be 
more heterogeneous. Therefore, MLST typing of the nine fucP negative and GGT negative 
isolates would be required to establish whether the ST-838, ST-1153, and ST-1614 evolved 
in different niches like C. jejuni ST-22 (GGT positive) and ST-1947 (GGT negative) 
(Revez  and  others  2011),  which  both  belong  to  ST-22  CC,  or  if  the  ST-828  CC  is  more  
heterogeneous than previously reported (Sheppard 2010; Sheppard and others 2013). 
GGT is an enzyme found in mammalian tissue and some bacteria, which cleaves 
and transfers the ?-glutamyl moiety from glutathione to amino acids or peptides. In 
Helicobacter spp., a genus closely related to Campylobacter, ggt is highly conserved in all 
species, and it is essential for the colonization of the gastric mucosa (Chevalier and others 
1999). In contrast, ggt is strain specific in C. jejuni, and its frequency has been reported to 
vary from 19.4% to 31.1%, as it is not essential for establishment of C. jejuni in the 
intestinal mucosa (Barnes and others 2007; Muraoka and Zhang 2011; de Haan and others 
2012). However, ggt contributes to the persistence of campylobacters in the gut for at least 
40 days once colonization is established (Hofreuter and others 2006; Barnes and others 
2007). 
In this study, the frequency of ggt in C. coli was assessed through a qualitative 
enzymatic assay, as the presence of ggt correlates  with  phenotype.  This  type  of  assay  
provides an inexpensive, reliable, and more direct indication of the presence of ggt (Barnes 
and others 2007; de Haan and others 2012). By this method 1.38% of the C. coli isolates 
were found to carry the ggt genes. 
Some studies in C. jejuni have suggested that ggt is more frequent in human 
isolates (Barnes and others 2007; Gonzalez and others 2009; Zautner and others 2011; 
Muraoka and Zhang 2011). However, the results of these studies might have been biased 
by the composition of the isolate collection, as it is strongly associated with certain STs (de 
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Haan and others 2012). The C. jejuni isolate collection screened by Zautner and colleagues 
(2011) was limited to certain CCs which are mostly GGT negative. Only one generally 
GGT positive CC; ST-45 which is commonly found among human isolates, was included 
in the collection, while Barnes and colleagues (2007), Gonzalez and colleagues (2009), and 
Muraoka and Zhang (2011) provided no MLST data on the isolates. In this study, the two 
GGT positive strains were isolated from a human patient and a Canadian goose. 
Consequently, although the number of GGT positive isolates in this study was limited, 
results seems to agree with de Haan and colleagues (2012) and Gripp and colleagues 
(2011), who observed no host association. 
Although the frequency of ggt in C. coli was found to be significantly lower (1.38%) 
than that observed for C. jejuni, this is an interesting finding, as the presence of ggt in C. 
coli has not been previously reported. Since some C. coli lineages have acquired 
substantial amounts of C. jejuni DNA, it may be hypothesized that the ggt genes found in 
the two C. coli isolates were the result of introgression with C. jejuni (Sheppard 2010; 
Sheppard and others 2013). Yet, both GGT positive strains neither belong to the 
introgressed CCs (ST-828 and ST-1150) nor were they closely related to these CCs. In fact, 
one of the isolates was identified as belonging to clade 3 (unpublished data) (Sheppard and 
others 2013). Furthermore, phylogenetic analysis of this isolate (unpublished data) 
revealed independent evolution of the gene in C. jejuni and C. coli.  Therefore,  as  in  the  
case of fucP, the frequency of ggt reported in this study might have been biased by the 
composition of the isolate collection. Thus, to approximate the actual distribution of ggt 
among C. coli, isolates belonging to clade 2 and 3 should be included in the screening.  
The presence of cytC,  which encodes a component of a cytochrome c oxidase has 
been reported to be strain specific (Hofreuter and others 2006; Barnes and others 2007). As 
in previous studies, only GGT positive C. jejuni strains were also cytC positive. This was 
expected as cytC is situated in the same locus as GGT, and the gene arrangement seems to 
be conserved among strains (Barnes and others 2007). Therefore, GGT and cytC are 
commonly regarded as mutually inclusive. 
In C. jejuni, diverse sialyltransferases (cst-I, cst-II, and cst-III) have been identified. 
The cst-II, which is observed in certain C. jejuni LOS classes (Parker and others 2008), 
generates ganglioside-like structures. Thus, its presence is linked to GBS (Yuki and others 
2004; Bax and others 2011). In this study, the presence of a cst-I-like, and a cst-V in C. coli 
was assessed by PCR. Both genes, cst-I and cst-V were detected at low frequencies in the C. 
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coli collection. Interestingly, one human isolate was positive for both sialyltransferases, 
while a swine isolate was cst-I positive. Nevertheless, results obtained in this study further 
support the findings by Richards and colleagues (2013), which identified three sialic acid 
orthologs in a contiguous cluster in two C. coli in  the  CPS and  in  the  LOS.  Although C. 
coli has been previously reported to not be implicated in GBS (Funakoshi and others 2006), 
these findings, in conjunction with those from Richards and colleagues (2013), suggest that 
C. coli may  potentially  cause  GBS,  and  that  both  LOS  and  CPS  might  be  involved  in  
ganglioside mimicry, as it has been previously suggested (Belkum and others 2009). 
 LOS are structures located on the surface of mucosal pathogens such as C. coli. 
These structures play an important role in adhesion and invasion of the intestine (Needham 
and Trent 2013). Additionally, differences in the LOS structure may protect bacteria from 
complement-mediated killing by mimicking human antigens. In C. jejuni 22 different LOS 
classes have been identified (Parker and others 2008; Richards and others 2013). Some of 
the LOS classes, which are sialylated, have been associated with GBS (Louwen and others 
2013). On the other hand, only nine LOS classes have been described for C. coli. These 
LOS classes have been reported to range from approximately 7 kbp to 18 kbp (Richards 
and others 2013). Nevertheless, in this study LOS ranging from approximately 3 kbp to 18 
kbp were found. This was surprising as most C. jejuni isolates from the same lineage have 
been reported to exhibit similar LOS classes (Revez and others 2011; Revez and Hänninen 
2012). As all the C. coli isolates were most likely from the same CC, a more homogenous 
result was expected. Moreover, it was hypothesized that strains from the same host would 
most  likely  exhibit  similarly  sized  LOS,  since  LOS  structures  strongly  interact  with  the  
host. Therefore, it was previously thought that an LOS structure which facilitated the 
colonization of a determined host would be homogenously distributed among isolates. 
However, different LOS sizes were widely spread among hosts. This suggests that isolates 
from  one  source  may  exhibit  more  than  one  LOS  class.  Additionally,  LOS  with  similar  
sized PCR products do not necessarily belong to the same class, as a LOS class is 
established according to the genes and their arrangement within the locus. Therefore these 
results strongly suggest that C. coli may have more LOS classes than those previously 
described, and that C. coli LOS are more variable than those of C jejuni.  
Sialyltransferase type II (cst-II) found in sialylated LOS classes in C. jejuni may 
provide bacteriophage resistance to bacteria in place of CRISPRs (Guerry and others 2000). 
CRISPRs provide bacterial immunity to phages and other alien elements mainly arise from 
the integration of short fragments (20 to 50 bp) of foreign DNA or spacers, followed by a 
40 
 
 
 
short palindromic repeat or DRs (Sorek and others 2013). The array of spacers and DRs is 
preceded by a group of cas (CRISPR associated) genes. Depending on the presence of the 
various cas genes, different types of CRISPR-cas systems can be identified (type I, II, III-
A, and III-B). CRISPR associated system type I is found in bacteria and archaea, while 
type II is present only in bacteria, and types III-A and III-B are mainly related to archaea. 
In C. jejuni CRISPR associated system type II has been observed (Louwen and others 2013; 
Dugar and others 2013). Therefore, the C. coli collection  was  screened  for  CRISPRs  by  
targeting cas2, which is found in CRISPR associated system type II.  
The proportion of CRISPR-PCR positive C. coli isolates (90.34%) was 
significantly higher than those previously reported for C. coli (0%-50%), but slightly lower 
than in C. jejuni (91.05%-97.54%) (Schouls and others 2003; Fouts and others 2005; Price 
and others 2007). The discrepancy between these and previous results, might have been 
due to the size of the sampling. In the studies by Schouls (2003), Fouts (2005), and Price 
(2007) only four, one, and seven C. coli isolates were tested, respectively. Conversely, in 
this study a total of 145 C. coli isolates from different sources were screened for CRISPRs. 
As a result, by increasing number of isolates, a better estimate of the frequency of 
CRISPRs in C. coli could be made. Yet, the distribution of CRISPRs in C. coli might have 
been underestimated in this study, as primers were not optimal for the amplification of 
CRISPRs in C. coli. At first, only 58 C. coli isolates were CRISPR-PCR positive. However, 
73 previously CRISPR-PCR negative isolates yielded a PCR product after the following 
modifications were made to the PCR protocol to increase the sensitivity of the reaction; 
increasing the volume of the reaction from 25 µl to 50 µl and the volume of the template 
from 2 µl to 5 µl, decreasing the annealing temperature 0.5 ºC, and increasing the number 
of cycles from 30 to 40. All the same, these modifications favoured the formation of non-
specific products, which were observed as secondary bands in 21 (16.03%) of the 
CRISPR-PCR  positive  isolates.  Additionally,  the  sequence  of  the  C. coli strain 76339 
revealed the presence of a CRISPR with four spacers (data not shown), but the strain 
yielded no PCR product upon repeated testing. The false negative result in strain 76339 
was due to the fact that this strain did not contain cas1 and cas2 genes, thus one of the 
primers could not bind. Furthermore, the binding site for the other primer was located in a 
different region of the genome from where the DRs and spacers were. As a result, no PCR 
product could be obtained, despite the presence of spacers and DRs. Therefore, 90.34% of 
CRISPR-PCR positives should be considered as the minimum and primers specifically 
designed for C. coli should be designed to reduce the number of false-negatives.  
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CRISPR-PCR products exhibited great variation in sizes; 300 bp to 2.2 kbp. 
Nonetheless, no association was observed between the size of the PCR products and source 
of isolation. Sequence analysis of 58 isolates reveled that 52 isolates (89.66%) carried 
CRISPRs regions (Table 9) with one to 14 spacers (Figure 9). Therefore, results suggest 
that C. coli may carry longer CRISPRs than C. jejuni, which have been reported to carry 
up to ten spacers in its CRISPRs locus (Schouls and others 2003; Price and others 2007). 
Interestingly, no CRISPRs genes were found in six of the sequenced CRISPR-PCR 
products. A similar observation was made in the studies by Hara and colleagues (2013) and 
Schouls and colleagues (2003), where 73.7% of C. lari and 15% of C. jejuni, respectively, 
carried no CRISPRs genes within their CRISPRs loci. Results therefore suggest that C. coli 
may carry cas genes but lack CRISPRs. Consequently, not all CRISPR-PCR positive 
isolates may be typeable by CRISPR sequencing.  
The DR was highly conserved among isolates. Only three isolates exhibited a 
single different DR in their CRISPRs. Two of the DRs were different in a single nucleotide 
while the other was more polumorphic. Nevertheless, all DR were characterized by a 
“GGTAAAAT” at the 3’ end as previously noted by Dugar and co-workers (2013). 
Blasting of the DR sequence against the CRISPR dabatabase revealed that C. jejuni and C. 
coli share highly similar DRs. 
Spacer polymorphism in C. coli was higher than that previously reported for C. 
jejuni (Schouls and others 2003; Price and others 2007). A total of 261 unique spacer 
sequences were found among 52 isolates, and thus, C. coli spacers were on average three 
times more diverse than those in C. jejuni.  Consequently,  a  large  proportion  of  CTs  
(86.54%) were unique: only two groups of swine C. coli comprised by isolates 150 and 
152, and 118, 120, 122, and 124, shared a common CT. Interestingly, both groups of 
isolates were obtained from the same swine farm in the same year. So based on these 
findings, it might be tempting to speculate that CRISPR-typing may be a useful tool for 
tracking the source of infection or contamination, or identifying clonal isolates. 
Nevertheless, the other 13 sequenced isolates from the same swine farm and year had 
unique  CTs.  In  the  instance  that  no  information  on  the  source,  such  as  exact  date  of  
isolation,  PFGE,  or  MLST  profile,  was  available  for  these  isolates,  it  could  have  been  
hypothesized that each group of isolates was clonal. However, the PFGE profiles (Juntunen 
and others 2010; Juntunen and others 2011) of isolates 150 and 152 were different, 
suggesting that CRISPR-typing is less discriminatory than PFGE. Isolates 150 and 152 
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originated from a swine farm in which piglets and sows were treated with antibiotics for a 
certain  period  of  time followed by  withdrawal.  As  a  result,  a  shift  in  PFGE profiles  was  
observed in C. coli isolates before and after antibiotic treatment. Although further research 
is required, this results may suggest that CRISPRs are more stable than PFGE profiles as  
150 and 152 might have shared a common ancestor and that the single band difference in 
the PFGE profiles could have been caused by the acquired erythromycin resistance by 152.  
Even though, C. jejuni is the commonly involved Campylobacter in outbreaks, a C. 
coli outbreak was recently documented among the male homosexual community in Canada 
(Gaudreau and others 2013), and therefore the possibility of C. coli outbreaks should not 
be ruled out. Consequently, a highly discriminatory typing method that is rapid, 
inexpensive, and simple, is required to identify outbreak related isolates among the 
numerous  sporadic  cases.  CRISPRs  sequence  analyses  have  been  shown  to  be  highly  
discriminatory. However, the usefulness of this discrimination power in outbreak 
investigation is yet to be determined since no outbreak isolates were included in this study. 
Furthermore, studies on the stability of CRISPR sequences after a passage through the GIT 
would be required. 
The extensive diversity of spacer sequences derived in a large percentage of spacers 
being source unique: 85.30%. This suggests that there is a lower spacer-overlap between 
different sources in C. coli than in C. jejuni (Schouls and others 2003). Nonetheless, a 
small percentage of spacers were found in more than one source; swine-poultry,  poultry-
human,  and  human-swine.  Therefore,  it  is  not  possible  to  relate  spacer  sequences  to  host  
origin. Additionally, blasting of spacer sequences against CRISPR database revealed 
spacer overlap between C. jejuni and C. coli. This may indicate the following: C. coli and 
C. jejuji are exposed to the same foreign DNA sources; or, that CRISPR spacers are 
transferred between species by horizontal gene transfer. Both scenarios are likely, as C. 
coli and C. jejuni tend to share the same niche and significant gene flow has been observed 
between these two species (Sheppard and others 2013). 
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7 CONCLUSIONS 
 In conclusion, GGT, fucP, and cytC seem to be lineage related in C. coli, and not 
host associated. Therefore, the frequency of these metabolic traits is highly dependent on 
the ST composition and diversity of the strain collection. Consequently, to obtain a clear 
distribution of these markers, C. coli belonging to clades 2 and 3 should be included in the 
screening. Additionally, inclusion of fucP,  GGT,  and  cytC in a virulence typing method 
like in S. enterica would not be useful as fucP is  widely  distributed  among  the  most  
commonly isolated CCs which are agriculture adapted, while the frequency of GGT and 
cytC in this niche is very low. CRISPRs were highly discriminatory. It may not be possible 
to use CRISPRs for identifying outbreak strains or sources of contamination on their own. 
However, in combination with PFGE or MLST it may increase their discrimination power 
or be used to clarify whether strains are related or not. Nevertheless, further research on the 
stability of CRISPRs is required. LOS sizes were highly variable, which indicates that 
more C. coli LOS classes exist than those currently known. The impact of this variability 
and the presence of sialylation in some of the LOS on human health, should be further 
explored. 
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APPENDIX 
A.1 Selective supplements for isolation of Campylobacter spp.  
 
Selective supplements for 500 ml of media for the isolation of Campylobacter species. Adapted from: 
Aspinall and others 1993; Blaser and others 1980; Bolton and others 1984; Bolton and others 1987; Karmali 
and others 1986; Skirrow 1977. 
  Selective supplement 
 Blaser-
Wang 
Bolton Butzler CAT CCDA CVA Karmali Preston Skirrow 
Amphotericin 
B (mg) 
1.0   5.0 5.0  2.0  5.0    
Bacitracin (IU)   12 500       
Cefoperazone 
(mg) 
 10.0  4.0 16.0 20.0 16.0   
Cephalothin 
(mg) 
7.5         
Cephazolin 
sodium (mg) 
  7.5       
Colistin 
sulphate (IU) 
  5 000       
Cycloheximide 
(mg) 
 25.0 25.0     50.0  
Novobiocin 
(mg) 
  2.5       
Polymyxin B 
(IU) 
1 250       2 500 1 250 
Rifampicin 
(mg) 
       5.0  
Sodium 
pyruvate (mg) 
      50.0   
Teicoplanin 
(mg) 
   2.0      
Trimethoprim 
(mg) 
2.5 10.0      5.0  2.5 
Vancomycin 
(mg) 
5.0 10.0    10.0 10.0  5.0 
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A.2 Spacers identification and distribution among sequenced isolates 
Spacers keys Isolates Source Position in CRISPRs Spacers sequences 
1 100 goose 1 GCACCTGTTTAAGATAAGAACGAAGCAACCA 
2 100 goose 2 CCAGCAAGTCGTGCAATTTTAATACACTGG 
3 100 goose 3 AATAATGATATTGAAGTTATTAATCTAATT 
5 101 pig 1 TCTTTAATAAGCATTAAATCATTGCCATTT 
153 pig 1 
177 pig 1 
97 pig 1 
6 101 pig 2 AAATTTCTTTATCGCCATAATCTGGATTTG 
15 pig 2 
7 104 pig 1 CTTCTTCGCTTGAAACTTGACAAAACATTG 
8 104 pig 2 TGAGATAGGAAATATAAATGCTGGAAATTC 
9 104 pig 3 CTTGGCGGTATTATGGCAAATTCAGTCAAC 
151 pig 5 
10 104 pig 4 TGATTTTTACGAGTTAAAAAATATTATAAA 
144 pig 13 
151 pig 9 
11 73 poultry 10 TTTTGTTGAGTGGGTTATGAGCCAAAATAA 
104 pig 5 
184 pig 2 
184 pig 4 
193 pig 5 
38 pig 9 
12 104 pig 6 CCTCTTAAATTAGAATTACAATTATCCAAT 
144 pig 8 
13 104 pig 7 TGGGGTGAAAACTCAATTAGTAAATGATGT 
14 104 pig 8 TACATTTACTTAAGTCTTTAAACTCAGGGT 
167 pig 9 
15 104 pig 9 CTTCTCAACTAATGAAAGCTTAGGTAAGGA 
16 104 pig 10 TATTATCTTCACTAATGCTATATTTACTAA 
17 104 pig 11 TCCATTCTCATAAAATATTTAGCCATTATT 
137 pig 1 
73 pig 6 
18 104 pig 12 ACCAAAAAGTGATAATCTTGCTTTTGGTAG 
19 104 pig 13 AATACACATTTTATTATATTTAATAAAAAA 
184 pig 6 
21 106 pig 1 GTAAAAAAGATGCATCTATTCCTGGAGATA 
22 106 pig 2 TTAATGCTATACAAGAATTTACAGTTGATT 
23 106 pig 3 TTCTCTTTCTATTTCAAACTTATCACCTAA 
24 106 pig 4 AAATAATTGAAAAAATAGCACATCATGTAT 
25 106 pig 5 ACCACCAAATATTTTAAATGATTTCAAAGA 
26 106 pig 6 TAAAACTGATTTTGATAATTTATACCCTTT 
27 106 pig 7 AATAGGTGTGTCAAAACTATTAAACTTACT 
28 106 pig 8 TACTTTATTCGAAGAAGATTTTTGCAAAGA 
29 106 pig 9 TCTTCTTGGTAAGGCTTAGGATTGTGTTTT 
30 111 pig 1 GCATACAAAGAGTAACCTCGCCCTATGAGAA 
143 pig 3 
148 pig 3 
150 pig 1 
152 pig 1 
31 111 pig 2 TATTGTTGATAAAGTTGATTTACTCTTTTA 
85 poultry 6 
32 111 pig 3 TTACGATTTAATGTATAAGCAAGACTTATC 
117 pig 2 
143 pig 4 
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148 pig 1 
163 pig 2 
84 poultry 1 
34 112 pig 1 TAAAGAAGGAGTTGAAAGAAACAAGGATTT 
35 112 pig 2 TTATTTTTGTCGCTAATTGCACCTAAAGAC 
36 112 pig 3 CAATGATTTTTCTTATTTGTAAAGCCATAG 
37 112 pig 4 AATACAGAAGTTGCATATAACTACGCAGTA 
189 pig 10 
38 112 pig 5 TGCAGCTTTAATGATAGCTTTAGTTTATAA 
39 112 pig 6 AAAATATTGCTATTTGCAAATAGAAACTGT 
112 pig 7 
40 112 pig 8 TAGGGCGAGGTTACTCTTTGTAGCTACAAA 
41 112 pig 9 AGTTCATTTAAGTTTTATATAAGAAAGCA 
112 pig 10 
42 112 pig 11 TTATACCACAAAAATATTTTTAAAAAATGT 
43 112 pig 12 TTGTAAGAATATGAATAGAAAAAAATTGAA 
44 112 pig 13 GAATTCGGAAAAGAGTGTTTAATTGAAGAT 
45 117 pig 1 TTAGAATTAACAAAGATTATCAAAATAGGT 
163 pig 1 
46 117 pig 3 ATACGGTTATAATGAACATCATAATAAGTC 
163 pig 3 
47 117 pig 4 TTTACAATTATAGGAAGTTCTAATGCTATA 
163 pig 4 
163 pig 5 
48 117 pig 5 TATACAGAGTTAAACAATATTAATGGAAAT 
163 pig 8 
49 117 pig 6 TTTGGTGGAGGCCAAACAAAAGAAGAAGTA 
163 pig 10 
50 118 pig 1 ACTATTATCGTTTGCTTTTGTAAGTCCTAA 
120 pig 1 
122 pig 1 
130 pig 1 
131 pig 1 
51 118 pig 2 TGATGCAAGTAGCGATATGTGGAATCCTGC 
120 pig 2 
122 pig 2 
130 pig 2 
131 pig 2 
52 118 pig 3 CAACAGAGAGTTTTTAAGTGCAAGTGATAT 
120 pig 3 
122 pig 3 
130 pig 3 
131 pig 3 
53 118 pig 4 CAATAATTCCTATGTATTGATTATCAATTC 
120 pig 4 
122 pig 4 
130 pig 4 
131 pig 4 
54 132 pig 1 CTTTTTTATTTTATAACCACAAATAAAAAC 
140 pig 1 
75 pig 3 
76 pig 1 
55 132 pig 3 GCAAGCGGGCAAACAGGTGCAGATGGACAC 
140 pig 2 
56 132 pig 3 TGCTATGAAGCTCTTTTCTGTTTGTGAAAT 
141 pig 2 
57 137 pig 2 AATCAAAAGCATTAAAGAAAAATACTGCAA 
58 137 pig 3 CTATTCTCCAATTATTGAAAGAACAGGGCA 
59 138 pig 1 CCGATTACATTCTTAACATTAGAATAGCTA 
60 
 
 
 
141 pig 1 
60 141 pig 3 TATTTTTTTCTTCATATTCTTTTAAAAGTT 
141 pig 4 
61 143 pig 1 CCTAACATACTAGCATTAGTATCTCTTGCA 
85 poultry 1 
62 143 pig 2 AGCAATTATTGTAACATTAACAGTTGTTAG 
85 poultry 2 
85 poultry 3 
63 143 pig 5 ATATCTGTAAACCTTACCATAGCAGAAGAA 
64 143 pig 6 TCCTGTTCCATAGCTTGCACTACCACTAAA 
65 143 pig 7 AGCTATACTTAATACAAAGTCAAAAGAATA 
87 human 7 
66 144 pig 1 TTTCTGATTTTAAATGATGCAAAAGCCCGT 
67 144 pig 2 GTAAATTTGTTTTCACTATCTAAGTTTGAG 
186 pig 4 
68 144 pig 3 AAAAAACAACTAGGGGTGAAAAAGAAGTTG 
69 144 pig 4 TTTTCCGCACTTTGAAAGATTTTATCTTTA 
75 poultry 11 
70 144 pig 5 TTTTGTCTTAAATAATAGCAGTTCACAAAA 
71 144 pig 6 AAAATCTTTAAATATCAATGGAGTAGATTT 
151 pig 1 
72 144 pig 7 TGGGTTAAAAAGTGGCGATGTAGGATATAC 
73 144 pig 9 TATACAAATTAAAAATTCTTTAGAAAAAGA 
74 144 pig 10 CAATATGGCAAAGTAGTTGTAAGAGATACA 
75 144 pig 11 ACAAGACAATTTATTAAAAATAGTAATGAA 
76 144 pig 12 TTGAAAACGATAATATTGCGGAACTTTCAC 
77 144 pig 77 CACGAGATACTAAATGCTAGTATGTTAGGTG 
78 144 pig 15 GAGCATTTGGAAAACAATGTTTTTATTATA 
79 148 pig 2 CAAATGTTAAAACAATACGAGCAAATGATT 
85 poultry 4 
80 148 pig 4 CAGGTTATGGAAATGGATTTAGAAGATGCG 
81 148 pig 5 TTGTAAATCATCATAAACATCATAGCACTG 
85 poultry 7 
82 148 pig 6 AATCCTCTTTCACCAGAGTATGGAGCTATT 
148 pig 9 
83 148 pig 7 ATTTATAAACAATGCTAGAATAGGCAGTAT 
148 pig 10 
84 148 pig 8 TTGTAAATCATNATAAACATNATANCACTN 
85 148 pig 11 GTTAAAACAATGGATCAAATGTTTTCAAGA 
86 148 pig 12 TGCCCCTTTTCTTCTTTAAGTTTTACCATTA 
174 pig 6 
88 150 pig 2 ATAATTATCTCCTGTATAATTATATTTAAT 
152 pig 2 
89 150 pig 3 GAAGAAAATGAAAAAACAGAAAGAATATTA 
152 pig 3 
90 150 pig 4 TATGATTAATAAGTACAGTGCAGGTGGTAA 
152 pig 4 
92 151 pig 2 GAAATGGTTATTAGTATCTTAAATGAAAGT 
151 pig 3 
73 poultry 13 
93 151 pig 4 TTATTATCTTTATTCTTATTATATATAGT 
72 poultry 4 
94 151 pig 6 AAAATATTTTAGATGAGTTGAAAGAAAGCT 
95 151 pig 7 TATCCAATTAGTAAATATAGCATTAGTGAA 
96 151 pig 8 AATAATGATATTGAAGTTATTAATTTAGTT 
97 151 pig 10 TACCAAATTCTTGCATATTAGCTACATTAG 
98 151 pig 11 TGTTTTATTAAAAGAAGATGGAGAAGAGAT 
99 151 pig 12 ATCACTCCATTTTATAATACAGTCAGTTTT 
100 151 pig 13 TTAAAAGTTTAGCTGAACTTGTTGAAAGAG 
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101 151 pig 14 AAATAAAGGAACAAAAATGAAAAAAAATTACA 
103 153pig poultry 3 TTAAGCAAATTTTGGCTTTGATCATCTTTT 
104 160 pig 1 TTAACCTAACAACATTATACAAAGACATAT 
105 160 pig 2 TAATAATGCTGTATTAACACAACTGCTTG 
106 160 pig 3 AGACCTGTGTTAGCTTCTCATATGGCTGGT 
107 160 pig 5 AGAACTTAATGATAATAATATTAGTATTGA 
189 pig 3 
108 160 pig 6 TACTAGCTTTATTAAAAAAGGAACTTATGT 
189 pig 3 
109 160 pig 7 GTTAAAAACTTAAACACATTTAAAATAGAT 
189 pig 4 
110 160 pig 8 TGTAGCTACAGCATTACTACCACTAGATAA 
189 pig 5 
111 160 pig 9 TTAATTAAATATTAACCCTCATCTAAATCC 
189 pig 6 
112 160 pig 10 GGATTATCTGTATCAATTGGAGGTTCAGGC 
113 160 pig 11 CAAGGTGGTAAACCATTAAAATATGCTCCA 
114 160 pig 12 ATTAATGCATAAACTTCATCACTCATATAA 
189 pig 7 
115 160 pig 13 TAATTTACTATACATTGTATTCCTTTTAAA 
189 pig 8 
116 160 pig 14 TTTAAGTAAGACATTAGAATGTGGGGCTAA 
118 163 pig 6 AGAAAAGTTTATGTCATGGATGAACCCTGA 
84 poultry 2 
119 163 pig 7 AAATCAGATCAATTTATGATAGATGCTGAT 
120 163 pig 9 TATAAAACTCTACACAATGTTTTAACTATT 
121 167 pig 1 GATGAAGATGAGGTTGAAGCTAAACAAGAT 
122 167 pig 2 ATTAGGTGCTAAATTTATTGATATGGTTGG 
123 167 pig 3 CAATAGTTGTTAAAAATGGTGATGATATTA 
124 167 pig 4 GCTTTCTGTGCTTTCAAACATATTGTCATA 
167 pig 7 
125 167 pig 5 TTAAAAGTTTAGGAGTATTTGCTACAAGAG 
126 167 pig 6 TAAACCCTTCTCCACCCTTTTGGAAGGGTG 
186 pig 3 
127 167 pig 8 AATTCTAAAAAAGCAGGATATGTTAGTAAA 
128 167 pig 10 GAAAAGTTAATATTATTAGCAACAAATGAA 
129 167 pig 11 TAAAATTATATAAGGCATAATGCATATGAA 
74 poultry 7 
130 170 pig 1 TATTTACACAAACAAAAGTTAAAGTTCATC 
131 170 pig 2 GCAATCATTGTAGCTTATGATGAGCTTATA 
132 170 pig 3 AGGAAGTATTATGATAGTATGTAATTATAA 
133 170 pig 4 TAATTTAAGAATAAAATATATGAAATCAAT 
134 170 pig 5 AGAGCCAGGTTACTATTATTTCAAGAATGG 
135 170 pig 6 GTAATGCTGTAGCTACAGTAAAAACAAATG 
74 poultry 2 
136 170 pig 7 AAAAGAGTTGAAAAGGCTTTAGAAAATACC 
137 170 pig 8 CAAGTGCTATAGTAGATAATTATGGAAATA 
74 poultry 5 
138 170 pig 9 TAAAAAATCTAAAATAGAGTTAAAAGTATC 
74 poultry 6 
139 170 pig 10 ATTTAATTTTTGGATTTTTTAGTGGCGATA 
140 170 pig 11 CCTTTTTTAGCTGTGCTTTTGGTTTCAAT 
141 170 pig 12 CTAAAGTTAGAAATTGCATCTATTAACCAT 
38 pig 2 
142 170 pig 13 TTTAGCTTTCTCACATATTTTACTTAACTC 
143 170 pig 14 GAAAATGGATATTTTTATGCAGTTAGCGG 
145 174 pig 1 AACACTTTAAGAAGTATCACAAAAAAAGAT 
146 174 pig 2 CAAGCTTTGCCCACTTGCTTTGTCTTCTAT 
147 174 pig 3 CCAAAACCTCTCCAATCCTTAGAAATCACC 
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148 174 pig 4 GGATTCGGTAGATAAAATCAGCTCCAGTTA 
149 174 pig 5 AAGTTTCAAGACCGATAGTCGTTGAAACTT 
150 174 pig 7 TAACCATTTTACCGAAGTTCAAAGCAGTTT 
151 174 pig 8 AGACAATCACTAAAGAACTTACGCATTTAA 
152 174 pig 9 CGTGAAGTTAGCCTAGAGCTAACGAACGGA 
153 174 pig 10 ATTTGGAATTGTATTAATTGTCAAAAAACT 
154 174 pig 11 GCGATTTTTTAGGAATTTCTTTATTTGTAG 
155 177 pig 2 CAATCACCCTTAAAGCTTTAGAGTTTTTGT 
156 177 pig 3 TAAAAAAGTAGATGATAGTAAACATAAACT 
97 pig 2 
157 177 pig 4 TATTGCCCCTGTCGTTTTCTTCACTAGGAT 
158 178 pig 1 TATGTTGCAATCTATGTTTGATGAGAGTCC 
159 178 pig 2 TCAAAACAAAATACAAAAAACTCTTCTAAA 
160 178 pig 3 CAGAAGATATATGATCTATTATTCTAGTAA 
161 178 pig 4 AGACTTTACAATTAAATAGCCACACTTTTA 
162 178 pig 5 GCTATTTTTACAAACATTTCAATCATTTTA 
163 184 pig 1 AATTGCTAGTCAATTAGGCTTGGATGATGC 
184 pig 3 
164 184 pig 5 ATAACAACCCATTCTTTATTTTCTAAATCA 
165 184 pig 7 CATTCTATAATTCCATTCTTATTTACATAA 
166 184 pig 8 AAATATGACAGCTAATATTGCCTTTAATAC 
38 pig 5 
167 186 pig 1 AAATTTGATGATAGCTTAGAAGTTGATTTG 
168 186 pig 2 ATACCTAACAATTTCGAAGCTGTAATTAAG 
169 189 pig 11 TCAAATAGCTGGGGAACTTTGGGAAAAACA 
170 189 pig 12 AATTAGCCGATGAAGTAGTTTGCCACTAA 
171 189 pig 13 ATAAAAAGGTAAAAAAAACAACACTAAACTT 
173 193 pig 1 AACACCTATGTATCCTATAACATCACCACG 
174 193 pig 2 CTTAAGTTTAATTTTGAAAGGATAAGCAAT 
175 193 pig 3 GAAAATATAATTGAAGCTAATAATGTAGTT 
176 193 pig 4 TTGACCATCTAGTCATGATATCTTTAAATCT 
177 193 pig 6 TTAACCATATTTTTTTCAACAAAAGTCATA 
178 193 pig 7 AGACAGTCAAGCGTTCCATCTGCTGTAGAA 
179 193 pig 8 CCTATAATACCTTTTACAAATATTGAAGGT 
180 193 pig 9 AGTTGCAGGTTCAGCAAATATAAATGTAAG 
181 193 pig 10 TGAGTTTGAAGGTGCTTTGAGCGTATTTAGT 
182 193 pig 11 TATTAAATGATAGTTTCTTAACATCTGTTG 
183 193 pig 12 TACCATCAGCACTAGCAGAAGCATTTAGTC 
184 193 pig 13 TATTATGTACCAAATAATATGAAGGGAATAT 
185 193 pig 14 GCAGGCGTAAAAACATTCTCTAGTTCAATG 
187 196 pig 1 TTCAGCTTTTAAACCAACAACTTCACTAAA 
87 human 4 
188 196 pig 2 CTACTAATAATTTCATGTATAACCTTTTGC 
189 196 pig 3 TACAATTAGAATCATATTTTAAAACAAGTG 
87 human 5 
190 196 pig 4 TTCTTTATTCAATAAATCATACTCATACAA 
191 196 pig 5 TAATTTACCTATTGAATTTCAATACAATGT 
192 196 pig 6 AGTGGGGTTAAGGGGTGCAACCCCTTACAA 
193 196 pig 7 TCCATCAATTGAAACACTACTTGCAAAACT 
87 human 6 
194 196 pig 8 ATAAACAAATCTATACCGATAACCTACAAG 
87 human 8 
195 31 pig 1 GCATTGCTATTACTACATAGCCAGTCGTGTA 
196 31 pig 2 AAAACTTGCATTTCTAGCAGTACTTCCAAA 
4 human 2 
72 poultry 9 
197 31 poultry 3 AAATCGTAGAGCAAAAACAATAGCGCGTGA 
4 human 3 
198 31 poultry 4 ATTGAAATTAACATTCATACCAGCAAGTAA 
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4 human 4 
199 33 poultry 1 GATTTATATTTTGAGTTGTCAAGAGAAATC 
87 human 1 
200 33 poultry 2 AAAACTTGCATTTCTTGCGGTGCTTCCAAA 
201 33 poultry 3 TAAAAAACCGTTAAGACAAAACTACCAGTT 
202 33 poultry 4 ATATAATATTTAAAATTTGCTATTGTTTTT 
203 33 poultry 5 TGATTTTTACNAGTTAAAAAATATTATAGA 
72 poultry 8 
75 poultry 1 
75 poultry 5 
204 33 poultry 6 GATTTTTCATTTAAATGATGATGAGTTAA 
72 poultry 12 
73 poultry 2 
205 33 poultry 7 GTCTCGTGCTATTGTTTTGGCTCTACGATT 
72 poultry 11 
206 33 poultry 8 TCCGTCCATATATACTGCGTCATCTTGTCC 
33 poultry 9 
207 33 poultry 11 CAAGTGATAGTATTATAAATAATGCAATAA 
208 33 poultry 12 CAGAGATAACGAGTTTAATTATACTAGAGA 
209 33 poultry 13 AGCAGAAGTTAAGGTAAGTGCCACTGGTGC 
211 38 pig 1 TGGGAAAAATCAGATCAATTTATGATAGAT 
212 38 pig 3 TATACTCTAAAGGTTCTCCTTCCCACACGT 
213 38 pig 4 TTTTTAAATTTTATACTCTCATCTATTATT 
214 38 pig 6 TTTATTGTGAGAAAGGAAAGTATAAAAGTT 
215 38 pig 7 TCAATAAAAAGATACATTATATACTGGTTT 
216 38 pig 8 CTTAGGACTTTTTATAAAAAAGCCTAGCAT 
217 38 pig 10 TTAGCAACTTATAATAACTCTAATGTTATT 
218 38 pig 11 GTTTCAACTTGACTTGCACCACATAAATAG 
219 38 pig 12 AATATAGATTTAAAAGAAAAATTAAAAGTA 
220 38 pig 13 ACTGCTATAAGAGGAGCTACTGGTCAAGAA 
72 poultry 3 
73 poultry 5 
221 38 pig 14 TTTAATCTTTCGCCATAGCTGTCTAATC 
223 4 human 1 GCATTGCTTTACAAAAAAGCCAGTCGTGTA 
224 67 human 1 TAAATATCCGTTATCATCTTTTGAACGCTT 
225 67 human 2 TAATTAACTATATTATAGGAGGAAAATGA 
226 67 human 3 TGCTGTGTTTCATCTCCTACCCATTTGTGT 
227 67 human 4 AGCAAAAAGTGATAAGTATTATATTGAAAT 
228 67 human 5 AAACATATCTTTTAACTTTATATTTGGATA 
229 67 human 6 AATCAAGAGCGCATAGGAAAAGATATATGT 
230 67 human 7 AAATCCGTTCGTTTTTAATATCATCAATAA 
231 72 poultry 1 TATAATAAAACCGNNNGTAATGCTGTTAAA 
75 poultry 4 
232 72 poultry 2 ATATTAAGTGATTATTTGAAAGGAAACAAA 
233 72 poultry 5 AGTTTTATTATAGCGAGACATAGCCCACCA 
234 72 poultry 6 ATTTATAAATTTGGATATGAAGCTTTAAGT 
72 poultry 7 
235 72 poultry 10 AAAATCCTTTAGCTATACAAAAATTAGATA 
236 72 poultry 13 CATTATTTATAATACTATCACTTGCTAAAA 
73 poultry 8 
238 73 poultry 1 TATCTAAAACCGCTTAGTAATGCTGTTAAA 
239 73 poultry 3 ATATCCATCTTTTATATCTTTAATCTTAAC 
240 73 poultry 4 TCAATTACGACAATATGTTTGAAAGCACA 
241 73 poultry 7 GGTAGTAGAATTATCTTTGCTGGTATCAAT 
242 73 poultry 9 GAGGTTATGGATATGGATATAGAAGATGCA 
243 73 poultry 11 GAAAGAAATTTTTTTATAGATTTACCACAC 
244 73 poultry 12 TGTTCTACTTTCAATCTCTTTAATTGTTTG 
245 74 poultry 1 TATAATAACAAACCATTAAAATATGCTCCA 
246 74 poultry 2 TTAAGGGTTGTTCTTGTAGATTAAAAATTT 
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74 poultry 4 
247 75 poultry 2 TGCCTTTAAAAGCTCGCAAGATGCTATGAA 
248 75 poultry 6 GAAAATCTTGACAAAATAAAATAAATATGT 
249 75 poultry 7 TAAGAGAATGCAAAATGTTTAGAAGTGATT 
250 75 poultry 8 CTTCTACTATTAGACATAATAGAGCGAGAG 
251 75 poultry 9 TCTTTTTGTGCTTTCACTTGCAGTTTTTGT 
252 75 poultry 10 AGTTCTTTTTAATTTAATTATAAAATCTTC 
253 75 poultry 12 ATGTTTTATTGTCAATAACACCTTTAGTTG 
254 75 poultry 13 GAAAATGGGTATTAGTATCTTAAATGAAAGT 
255 75 poultry 14 GGCACTCTTTTAATATTATAAAACTGGACTT 
256 76 poultry 2 TCCATTTGATGAAGACTGGAGTGCTTTTGT 
257 76 poultry 3 ATTTTGAACATCCATATGCCATGTTGAATA 
258 84 poultry 3 TGGTGGTGTATCACTCTGTAAAGATATTAT 
259 84 poultry 4 TGCGTTGTAAAAGAATATGGTGCAGGAAGT 
260 84 poultry 5 GCAGTTAATATAACAGTTACAGCAAGTAAT 
261 84 poultry 6 GGTGGGGATGAAGAGCAAGTTGTACAACTA 
262 84 poultry 7 AAGGCAAAGATTTTTTCGACAAATGGTGGA 
263 84 poultry 5 GCTACAAAGAGTAATCTCGCCCTATGAGAA 
264 87 human 2 ACAAGCTGTTAAATCAGGTAATAAGATTCA 
265 87 human 3 TGATAATATGTGGAATAATATTTCTTTAGG 
266 87 human 9 CGATTTAATTTCTTCAATACAAATAAGTAT 
267 87 human 10 CACTCTTCATTTATCTTGGTTTTTGTCTTG 
268 87 human 11 AGATATTTCCCACAAACAAAGTGGGAACTA 
270 95 pig 1 AAATCATAAAAGTAATTGGTTATGAGAACG 
